Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Psoriasis

• A Study to Evaluate the Safety and Tolerability, and the Efficacy of Si-544 in Adults With Psoriasis Vulgaris or Psoriatic Arthritis
• A Clinical Study to Compare the Safety and Pharmacokinetics of SHR-1314 Injection in Healthy Subjects at Different Specifications Devices
• A Study of LY3972406 in Adult Participants With Moderate-to-Severe Plaque Psoriasis
• A Study of QY101 Ointment in Subjects With Plaque Psoriasis
• A Clinical Study of TQH2929 in Healthy Adult Subjects
• Methotrexate Alone vs Combination With Excimer Light in Nail Psoriasis
• A Study of JNJ-77242113 for the Treatment of Participants With Moderate to Severe Plaque Psoriasis
• Phase I Randomized, Open-label, Parallel-controlled, Pharmacokinetic and Safety Study of BR201 Injection Versus Cosentyx in Healthy Male Subjects
• Efficacy and Safety Study of HRO350 in Patients With Mild-to-moderate Psoriasis (the 'HeROPA' Study).
• A Study to Investigate Efficacy and Safety of Apremilast 30 mg Twice Daily (BID) in Chinese Participants With Moderate to Severe Plaque-type Psoriasis (PsO)
• Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of ICP-488 in Patients With Moderate to Severe Plaque Psoriasis
• A Study About How Well TAK-279 Works and Its Safety in Participants With Moderate-to-severe Plaque Psoriasis During 60 Weeks of Treatment With a Withdrawal and Retreatment Period
• Vtama in Psoriasis Patients Being Treated With Biologics.
• A Study of JNJ-77242113 in Adolescent and Adult Participants With Moderate to Severe Plaque Psoriasis
• A Study of JNJ-77242113 for the Treatment of Participants With Plaque Psoriasis Involving Special Areas (Scalp, Genital, and/or Palms of the Hands and the Soles of the Feet)
• A Study of Apremilast in Pediatric Participants in Children With Mild to Moderate Plaque Psoriasis
• A Study About How Well TAK-279 Works and Its Safety in Participants With Moderate-to-severe Plaque Psoriasis During 52 Weeks of Treatment
• Bioequivalence Study of Two Products of Apremilast 30 mg Tablets in Healthy, Adult, Human Subjects
• A Study to Evaluate Efficacy and Safety of HS-10374 for Moderate to Severe Plaque Psoriasis
• A Study to Evaluate Efficacy and Safety of SAR441566 in Adults With Plaque Psoriasis
• A Study to Evaluate the Efficacy and Safety of AK111 in Subjects With Moderate to Severe Plaque Psoriasis
• To Evaluate the Efficacy and Safety of AK111 Injection in the Treatment of Moderate to Severe Plaque Psoriasis
• Efficacy and Safety of Jiuweihuaban Pill for Treating Plaque Psoriasis
• IBI112 in Moderate to Severe Plaque Psoriasis With Randomized Withdrawal and Re-treatment
• A Study to Evaluate Effectiveness and Safety of Deucravacitinib in Participants With Non-Pustular Palmoplantar and Genital Psoriasis
• Anti-Inflammatory Effects of 0.045% Tazarotene/0.01% Halobetasol Lotion in Psoriasis
• Study of Guselkumab Versus Placebo for the Treatment of Low Body Surface Area Moderate Plaque Psoriasis
• A Study to Test Whether Spesolimab Helps People With Generalized Pustular Psoriasis (GPP) Who Need Treatment for Repeated Flares
• A Study to Evaluate the Efficacy and Safety of Bimekizumab in Chinese Adult Study Participants With Moderate to Severe Plaque Psoriasis
• Study Evaluation of the Efficacy, Safety and Immunogenicity of Adalimumab in Comparison With Humira®
• Comparison of Post-Inflammatory Pigment Alteration After Psoriasis Treatment (PIPA - Dermavant)
• Study to Assess the Safety and Efficacy of Subcutaneously Injected Risankizumab in Adult Participants With Genital or Scalp Psoriasis
• A Study to Investigate Efficacy and Safety With LEO 90100 Compared With Daivobet® Ointment in Adult Chinese Subjects With Stable Plaque Psoriasis
• Using Acetylcysteine and Vitamin E With Psoriasis Vulgaris
• A Study to Evaluate the Efficacy and Safety of DC-806 in Participants With Moderate to Severe Plaque Psoriasis
• Outcome of Treatment With Secukinumab in the Treatment of Moderate to Severe Plaque Psoriasis at Tertiary Care Hospital.
• Effect of Adalimumab Therapy on Psoriasis Patient
• A Demonstration of the Hair and Scalp Benefits of Duobrii in Scalp Psoriasis
• Correction of Psoriatic T Cell Signatures by Deucravacitinib
• Immune Spatial Features of Guselkumab Cutaneous Response
• An Investigational Study to Evaluate Experimental Medication SYHX1901 Tablets With Moderate to Severe Plaque Psoriasis
• A Study of Ixekizumab (LY2439821) in Participants Aged ≥18 Years With Moderate-to-Severe Plaque or Active Psoriatic Arthritis in India
• Shuiniujiao Dihuang Decoction With Variation for the Treatment of Psoriasis
• A Study to Investigate Efficacy and Safety of VTAMA® (Tapinarof) Cream, 1% in Plaque Psoriasis in the Head and Neck Region
• The Efficacy and Safety of TLL018 in Moderate-to-severe Plaque Psoriasis
• Bioequivalence Study of Two Treatments for the Treatment of Plaque Psoriasis
• Open-Label Extension Study to Evaluate the Long Term Safety and Efficacy of ESK-001 in Plaque Psoriasis
• A Study to Evaluate Effectiveness and Safety of BMS-986322 in Participants With Moderate-to-Severe Psoriasis
• A Study to Test How Well Different Doses of BI 765250 Are Tolerated by People With a Skin Disease Called Plaque Psoriasis
• Quantitative Fluorescence Molecular Imaging of Ustekinumab-800CW to Elucidate the Drug Distribution Throughout Inflamed Tissue in Crohn's Disease and Psoriasis.
• Proof of Concept Study of AX-158 in Patients With Mild to Moderate Plaque Psoriasis
• A Safety, Tolerability and Pharmacokinetics Study of Topical Ointment YR001 in Adult Healthy Volunteers
• Deucravacitinib for the Treatment of Palmoplantar Pustulosis
• Phase II Study Evaluating the Clinical Efficacy and Safety of GN-037 in Plaque Psoriasis
• A Study to Evaluate the Effect of Deucravacitinib on Quality of Life in Participants With Plaque Psoriasis in a Community Setting
• Roflumilast Versus Methotrexate in Psoriasis
• A Study to Investigate Efficacy and Safety of VTAMA (Tapinarof) Cream, 1% in Intertriginous Plaque Psoriasis
• VTX958 Versus Placebo for the Treatment of Moderate to Severe Psoriasis
• A Study to Evaluate IBI112 in the Treatment of Psoriasis With Moderate to Severe Plaque Psoriasis
• Study of SFA002 in Patients With Mild to Moderate Psoriasis Plaques
• A Phase 2 Study of Recombinant Anti-IL-17A Humanized Monoclonal Antibody in Chinese Participants With Moderate-to-Severe Plaque Psoriasis
• Adherence to Otezla
• A Study to Evaluate the Efficacy and Safety of ESK-001 in Patients With Plaque Psoriasis
• A Study to Assess the Efficacy and Safety of Apremilast in Japanese Pediatric Participants With Moderate to Severe Plaque Psoriasis
• Excimer Laser With Topical Agents in Psoriasis Vulgaris
• A Phase 3 Study of Recombinant Anti-IL-17A Humanized Monoclonal Antibody in Chinese Participants With Moderate-to-Severe Plaque Psoriasis
• A Study to Evaluate the Efficacy and Safety of HB0017 in Patients With Moderate to Severe Plaque Psoriasis
• Safety and Tolerability Study of MSC Exosome Ointment
• KX01 Ointment Phase 1 Study in Patients With Plaque Type Psoriasis
• A Phase 1 Study to Assess Single and Multiple Ascending Doses of PBI-100 Topical Cream
• HB0034 in Patients With Generalized Pustular Psoriasis (GPP)
• Pharmacokinetics, Efficacy, Safety, and Immunogenicity of SB5 Versus Humira in Subjects With Moderate to Severe Chronic Plaque Psoriasis
• A Study of AK111 in Subjects With Moderate-to-severe Plaque Psoriasis
• Effect of Bimekizumab in Patients With Psoriasis Vulgaris and Active Psoriatic Arthritis
• Efficacy and Safety of Novel Formulations of Topical Calcipotriol in Patients With Mild to Moderate Plaque Psoriasis
• Efficacy and Safety of Deucravacitinib Versus Placebo in Participants With Moderate-to-severe Scalp Psoriasis
• Bioavailability and Tolerability of Fexofenadine Hydrochloride Topical Lotion 1%
• A Study to Investigate Safety, Tolerability and Clinical Response With SAR441566 Compared With Placebo in Participants With Mild to Moderate Psoriasis
• A Clinical Study of ICP-488 in Healthy Subjects and Patients With Psoriasis
• Topical SGX302 for Mild-to-Moderate Psoriasis
• Phase I Study of GN-037 Cream for Psoriasis
• Evaluation of the Effect of Narrowband UVB Versus Methotrexate on Serum Chitotriosidase Level in Psoriasis
• Intralesional Injection Of Methotrexate Versus Triamcinolone Acetonid In Treatment Of Localized Psoriasis
• Effect of Acitretin Versus Narrowband Ultraviolet B on Neopterin Level in Psoriatic Patients .
• Psoriatic Immune Response to Tildrakizumab
• Assessment on Efficacy and Safety of BAT2306 and Cosentyx® in Plaque Psoriasis Patients
• A Study To Learn About The Safety, Efficacy and Tolerability of PF-07038124 Ointment In Participants With Mild-To-Moderate Atopic Dermatitis Or Mild-To-Severe Plaque Psoriasis
• A Long-term Extension Study of JNJ-77242113 in Participants With Moderate-to-Severe Plaque Psoriasis
• A Study of JNJ-77242113 for the Treatment of Moderate-to-Severe Plaque Psoriasis
• Study to Evaluate the Efficacy and Safety of Imsidolimab (ANB019) in the Treatment of Subjects With GPP
• Phase Ib Study to Evaluate the Safety and Efficacy of TLL018 in Patients With Plaque Psoriasis
• Safety, Tolerability, PK, PD and Preliminary Efficacy of ONO-4685
• Efficacy and Safety of Benvitimod Cream in the Retreatment of Mild to Moderate Psoriasis
• Chinese Medicine for Patients With Psoriasis
• High Dose Risankizumab for Psoriasis
• A Study Comparing Halobetasol Propionate and Tazarotene Topical Lotion 0.01%/0.045% to Duobrii® Lotion (Halobetasol Propionate and Tazarotene Lotion), 0.01%/0.045% (Reference Listed Drug) in the Treatment of Moderate to Severe Plaque Psoriasis.
• Study of Guselkumab in Skin of Color Participants With Moderate-to-severe Plaque and/or Scalp Psoriasis
• Development of Predictive Psoriasis Response Endotypes Using Single Cell Transcriptomics
• Efficacy and Safety of ME3183 in Subjects With Moderate to Severe Plaque Psoriasis
• Clinical Trial of Probiotic Supplementation in Psoriasis Vulgaris
• A Study of Ustekinumab in Pediatric Participants
• A Phase III Study in Subjects With Mild to Moderate Psoriasis.
• An Expanded Access Program in China to Provide Spesolimab to People With a Flare-up in Generalized Pustular Psoriasis Who Have no Other Treatment Options
• A Study of JNJ-77242113 in Participants With Moderate-to-severe Plaque Psoriasis
• Omentin-1 Level in Psoriatic Patients Treated With Narrowband Ultraviolet B Phototherapy Versus Acitretin
• Investigator Initiated Trial to Study Duobrii® Lotion in the Treatment of Mild Plaque Psoriasis in Adults
• An Expanded Access Trial in Japan to Provide Spesolimab to People With a Flare-up in Generalized Pustular Psoriasis Who Have no Other Treatment Options
• A Phase 2b Study to Evaluate RIST4721 in Palmoplantar Pustulosis (PPP)
• Study to Assess the Efficacy and Safety of Orismilast in Psoriasis
• Residual Disease MEMory in PSOriasis Skin During EnstiLAR® and Narrow-band Ultraviolet B Therapy: The MEMPSOLAR Study
• Plexin B2 Gene Expression and Polymorphisms in Psoriasis : Relation to Narrow Band Ultraviolet B , Acitretin and Combined Therapy
• A Clinical Trial to Evaluate Efficacy and Safety of Two Different Formulations of Topical Calcipotriol in Patients With Mild to Moderate Plaque Psoriasis
• Phase 3, Randomized Study of Apremilast in Japanese Participants With Palmoplantar Pustulosis (PPP)
• Tapinarof for the Treatment of Plaque Psoriasis in Pediatric Subjects
• Etanercept Therapy for Nails Psoriasis Monitoring With Noninvasive Imaging
• Effect of Guselkumab on Cardiovascular Risk Surrogate Markers in Participants With Moderate to Severe Plaque Psoriasis
• An Investigator Initiated Open Label Study Evaluating the Efficacy and Tolerability of Oral Deucravacitinib for the Treatment of Nail Psoriasis
• A Phase 3 Study of Efficacy and Safety of AK101 in Subjects With Psoriasis
• A Phase Ⅲ Study to Evaluate Tildrakizumab in the Treatment of Chinese Subjects With Moderate to Severe Plaquetype Psoriasis
• A Comparative Study Between ABP 501 and Humira® in Participants With Moderate to Severe Plaque Psoriasis
• Study of Efficacy and Safety of Investigational Treatment in Patients With Nail Psoriasis
• Phase IV Clinical Study of Benvitimod Cream in the Treatment of Mild to Moderate Psoriasis in Adults
• A Study to Assess Adverse Events and Disease Activity With Cedirogant (ABBV-157) in Adult Participants With Moderate to Severe Psoriasis
• Sequential Treatment of Psoriasis With Traditional Chinese and Western Medicine
• Topical Roflumilast to Treat Scalp and Body Psoriasis (ARRECTOR)
• A Study to Evaluate the Efficacy and Safety of Bimekizumab in Adult Korean Study Participants With Moderate to Severe Plaque Psoriasis
• Multi-Center PAMPA Study
• A Study to Evaluate IBI112 in the Treatment of Psoriasis With Moderate to Severe Plaque Psoriasis
• Study of NDI-034858 in Subjects With Moderate to Severe Plaque Psoriasis
• Pilot Study of Traditional Chinese Medicine (Qing-Re-Liang-Xue Decoction) as Complementary Medicine for Psoriasis Vulgaris of Blood-heat Syndrome.
• A Study of LY3361237 in Participants With Psoriasis
• Topical Methotrexate Microemulsion in the Treatment of Plaque Psoriasis
• A Study to Compare SB17 (Proposed Ustekinumab Biosimilar) to Stelara® in Subject With Moderate to Severe Plaque Psoriasis
• Efficacy, Safety, and Immunogenicity of AVT04 With Moderate-to-Severe Chronic Plaque Psoriasis
• EDP1867 Phase 1a/1b Study in Healthy Participants and Participants With Moderate Atopic Dermatitis and, Optionally, Moderate Psoriasis, and/or Mild Asthma
• A Study of Guselkumab (TREMFYA) in Chinese Participants With Moderate to Severe Plaque Psoriasis
• A Study to Investigate Efficacy and Safety of KBL697 in Patients With Moderate Plaque Type Psoriasis
• A Clinical Trial to Evaluate the Safety, Tolerability, and Efficacy of Subjects With Plaque Psoriasis
• Study of Subcutaneous Risankizumab Injection Compared to Oral Apremilast Tablets to Assess Change in Disease Activity And Adverse Events in Adult Participants With Moderate Plaque Psoriasis Who Are Candidates for Systemic Therapy
• Study to Evaluate Adverse Events and Change in Disease Activity in Participants Between 6 and 17 Years With Moderate to Severe Plaque Psoriasis Treated With Subcutaneous (SC) Injection of Risankizumab Who Have Completed Participation in Study M19-97
• A Dose-Ranging Phase II Study of AUR101 in Psoriasis (INDUS-3)
• Bioequivalence Phase I Study of BFI-751 Compared With EU and US-STELARA® in Healthy Adults
• A Phase Ⅲ Efficacy and Safety Study of Hemay005 in Subjects With Moderate to Severe Plaque Psoriasis
• Efficacy 、Safety and PK of SHR-1314 in Patients With Moderate-to-Severe Plaque Psoriasis
• Multiple Ascending Dose Study to Assess Safety and Pharmacokinetics of Hemay005 In Healthy Subjects
• Evaluation of the Effect of Narrowband UVB Versus Methotrexate on Serum TWEAK Level in Psoriasis
• Evaluate the Efficacy and Safety of Boroda Supramolecular Active Zinc in the Treatment of Scalp Psoriasis
• Efficacy, Safety, and Immunogenicity of Subcutaneous DMB-3115 Versus Stelara® in Patients With Moderate to Severe Chronic Plaque Psoriasis
• Comparison of PSORI-CM01 Formula vs Gu Ben Hua Yu Formula Combined With AD-MSCs in Psoriasis
• A Proof-of-Activity Study With Orticumab in Subjects With Psoriasis and Cardiometabolic Risk Factors
• A Study to Evaluate the Drug Levels, Efficacy and Safety of BMS-986165 in Adolescent Participants With Moderate to Severe Plaque Psoriasis
• A Study to Investigate Interchangeability of ABP 654 for the Treatment of Participants With Moderate to Severe Plaque Psoriasis
• Maximal Usage Pharmacokinetics and Safety of ARQ-151 in Children With Plaque Psoriasis (ARQ-151-216)
• Pharmacokinetics, Safety and Tolerability Study of AVT04 to EU Approved and US Licensed Stelara (Ustekinumab)
• Comparative Study of BAT2206 With Stelara® in Patients With Moderate to Severe Plaque Psoriasis
• Exploring the Effects of IL-23 Inhibition by Risankizumab on Psoriasis Autoimmunity
• Combination of Halobetasol Propionate and Tazarotene Lotion (Duobrii®) for Palmoplantar Plaque Type Psoriasis
• A Study to Assess the Pharmacokinetics, Safety, and Efficacy of Two Doses of Bimekizumab in Adolescent Study Participants With Moderate to Severe Plaque Psoriasis
• Study of Subcutaneous (Injected Under the Skin) Risankizumab to Assess Change in Disease Symptoms in Adult Participants With Moderate to Severe Plaque Psoriasis With Palmoplantar Involvement
• Comparative Study to Evaluate the Pharmacokinetics of BAT2306 vs Cosentyx® in Healthy Subjects
• Study To Assess Efficacy, Safety, Tolerability And Pharmacokinetics Of PF-07038124 Ointment In Participants With Atopic Dermatitis Or Plaque Psoriasis
• Maximal Usage Pharmacokinetics and Safety of ARQ-151 in Children With Plaque Psoriasis (ARQ-151-215)
• Guselkumab Immunogenetics
• Risankizumab Long-term Remission Study
• Rimegepant in Moderate Plaque-type Psoriasis
• A Phase 4 Study of Brodalumab (KHK4827) in Subjects With Moderate to Severe Plaque Psoriasis
• A Phase 2 Study of Jaktinib in Participants With Moderate to Severe Psoriasis
• A Study to Investigate ABP 654 for the Treatment of Participants With Moderate to Severe Plaque Psoriasis
• A Phase 2 Study Investigating the Effect of EDP1815 in the Treatment of Mild to Moderate Plaque Psoriasis
• A Double-blind Study to Compare the Efficacy, Safety, and Immunogenicity of the Proposed Biosimilar Ustekinumab FYB202 to Stelara® in Patients With Moderate-to-Severe Plaque Psoriasis
• A Study Evaluating the Effects of GLPG3667 Given as an Oral Treatment for 4 Weeks in Adults With Moderate to Severe Plaque Psoriasis
• Assessing the Efficacy of Image-guided Laser-assisted Enstilar® Delivery for Treatment of Psoriatic Nails
• Apremilast in Patients With Moderate to Severe Palmoplantar Pustulosis (PPP) (APLANTUS)
• A Study to Evaluate the Efficacy and Safety of Secukinumab in Adult Patients With Skin Types IV-VI With Moderate to Severe Plaque Psoriasis
• Efficacy and Safety of Sorilux in Maintenance Treatment of Moderate Type Plaque Psoriasis
• To Assess the Effect of SCD-044 Treatment on Moderate to Severe Plaque Psoriasis
• The Maintenance Effect of Enstilar Foam in Combination With Otezla
• Efficacy of Roflumilast in the Treatment of Psoriasis
• Outcomes With Treatment and Withdraw of Ixekizumab in Patients With Plaque Psoriasis
• Open Label Study of the Effects of Secukinumab on Nail Psoriasis and Non-Invasive Measures of Enthesitis (Phase IV)
• Danish Population-based Assessment of Psoriasis and Psoriatic Arthritis (DANPAPP)
• A Study to Test Long-term Treatment With Spesolimab in People With Palmoplantar Pustulosis (PPP) Who Took Part in Previous Studies With Spesolimab
• Methotrexate Versus Secukinumab Safety in Psoriasis Patients With Metabolic Syndrome
• Study of Subcutaneous Risankizumab Injection to Assess Change in Palmoplantar Pustulosis Area and Severity Index [PPPASI] in Adult Japanese Participants With Palmoplantar Pustulosis
• A Study of Subcutaneous Risankizumab Injection for Pediatric Participants With Moderate to Severe Plaque Psoriasis to Assess Change in Disease Symptoms
• SystemIc iNflammation and Microvascular diSease PreventIon in psoRiatic diseasE
• Oral Chinese Herbal Medicine Concurrent With Secukinumab for Severe Plaque Psoriasis
• A Study to Test Whether BI 655130 (Spesolimab) Prevents Flare-ups in Patients With Generalized Pustular Psoriasis
• An Explorative Psoriasis Biomarker Study
• Taltz in Combination With Enstilar for Psoriasis
• Comparative Study to Evaluate the Pharmacokinetics of BAT2206 vs Stelara® in Healthy Subjects
• Randomized, Double Blinded, Placebo Controlled, Single Dose Escalation Study of 608 in Healthy Subjects
• ILUMYA in Combination With HALOG Ointment 0.1% for Plaque Psoriasis.
• Dose Reduction of IL17 and IL23 Inhibitors in Psoriasis
• A Study to Evaluate the Benefit and Safety of GSK2982772 in Moderate to Severe Psoriasis Participants
• Efficacy and Safety of Brodalumab in Adolescents From 12 to 17 Years of Age With Moderate-to-severe Plaque Psoriasis
• Open-Label Extension Trial of PDE4 Inhibition With Roflumilast for the Management of Plaque Psoriasis
• Maximal Usage Pharmacokinetics and Safety of ARQ-151 in Adolescents and Adults With Chronic Plaque Psoriasis
• Efficacy and Safety of AD-MSCs Plus Calpocitriol Ointment and PSORI-CM01 Granule in Psoriasis Patients
• Role of Reverse Transcriptase Inhibitors in the Treatment of Psoriasis
• MIcrovascular dysfuNction In Moderate-severe Psoriasis
• Efficacy and Safety of Tildrakizumab in Participants With Moderate-to-Severe Chronic Plaque Psoriasis Who Are Non-Responders to Dimethyl Fumarate Therapy
• Efficacy of Low Dose Naltrexone in Psoriasis
• Tofacitinib for Immune Skin Conditions in Down Syndrome
• A Study of the Safety and Efficacy of UHE-105 Shampoo in Subjects With Scalp Psoriasis
• Outcomes With Treatment and Withdraw of Secukinumab in Patients With Plaque Psoriasis
• Efficacy and Safety of Tildrakizumab 100 Milligrams (mg) in Participants With Moderate-Severe Chronic Plaque Psoriasis and Its Impact on Their Quality of Life (TRIBUTE)
• A Study Evaluating the Efficacy and Tolerability of Enstilar Foam in Patients With Nail Psoriasis
• Study to Evaluate the Safety and Antipsoriatic Efficacy of BOS-475 in a Psoriasis Plaque Test
• Twin Trial of PDE4 Inhibition With Roflumilast for the Management of Plaque Psoriasis
• Trial of PDE4 Inhibition With Roflumilast for the Management of Plaque Psoriasis
• A Phase II Study to Evaluate Efficacy & Safety of AUR101 in Patients of Moderate-to-Severe Psoriasis
• A Study of DLX105-DMP in Subjects With Plaque Psoriasis
• A Phase 4 Clinical Study of Brodalumab
• A Long-term Extension Study of Apremilast (CC-10004) in Pediatric Subjects From 6 Through 17 Years of Age With Moderate to Severe Plaque Psoriasis
• An Investigational Study to Evaluate Experimental Medication BMS-986165 Compared to Placebo in Participants With Plaque Psoriasis (POETYK-PSO-3) in Mainland China, Taiwan, and South Korea
• A Study in Pregnant Women With Chronic Inflammatory Diseases Treated With Cimzia (Certolizumab Pegol)
• A Safety Study of LY3462817 and LY3509754 in Participants With Psoriasis
• A Study of Brodalumab (SILIQ®) in Psoriasis Participants With Inadequate Response to Their Current Biologic Agent Regimen
• Ayurvedic Treatment Package in Plaque Psoriasis
• Safety and Efficacy of ARQ-154 Foam in Adolescent and Adult Subjects With Scalp and Body Psoriasis
• A Study to Evaluate the Efficacy, Safety, and Drug Concentration of Certolizumab Pegol (CZP) in Children and Adolescent Study Participants With Moderate to Severe Chronic Plaque Psoriasis (PSO)
• A Study of LY3471851 in Participants With Psoriasis
• Duobrii in Combination With Biologics
• Psoriasis、Indigo Naturalis、Chinese Medicine Medicated Bath
• A Study to Evaluate the Effects of Single and Multiple Oral Doses of GLPG3970
• Efficacy and Safety Study of Hemay005 in Subjects With Moderate to Severe Plaque Psoriasis
• A Study of the Safety and Efficacy of Risankizumab in Adult Participants With Plaque Psoriasis Who Have Had a Suboptimal Response to Secukinumab or Ixekizumab
• A Safety Study of 188-0551 Spray Versus Reference Listed Drug (RLD) in Adult Subjects With Plaque Psoriasis
• Turmeric Based Therapy in the Treatment of Psoriasis: A Clinical Trial
• A Study of KHK4827 in Subjects With Palmoplantar Pustulosis
• A Study to Evaluate the Efficacy and Safety of Apremilast (CC-10004) in Japanese Subjects With Palmoplantar Pustulosis
• Long Term Extension Study of Tapinarof for Plaque Psoriasis in Adults (3003)
• Maximal Use Study of Tapinarof Cream, 1% in Adults With Extensive Plaque Psoriasis
• Long-Term Study That Measures the Safety and Efficacy of Deucravacitinib (BMS-986165) in Participants With Psoriasis
• Triamcinolone With Vitamin D Synergistic Efficacy in Psoriasis
• Dose Tapering Study of Adalimumab in Psoriasis
• Comparison of PK and Tolerability of MSB11022 Administered by AI or PFS
• A Study to Test How Effective and Safe Different Doses of BI 655130 Are in Patients With a Moderate to Severe Form of the Skin Disease Palmoplantar Pustulosis
• A Study of Guselkumab for the Treatment of Palmoplantar-non-Pustular Psoriasis
• A Study of Tildrakizumab in Pediatric Subjects With Chronic Plaque Psoriasis
• Adrenal Suppression and Absorption Study of Halobetasol Propionate Foam in Subjects 12-17 With Plaque Psoriasis
• Benefit of Placebo and Different Concentrations of Triamcinolone Acetonide in Nail Psoriasis
• A Safety and Pharmacokinetics Study of IDP-118 Lotion in Pediatric Participants With Plaque Psoriasis
• A Study to Evaluate RIST4721 in Palmoplantar Pustulosis (PPP)
• A Safety and Pharmacokinetics Study of IDP-122 Lotion in Pediatric Participants With Plaque Psoriasis
• Tapinarof for the Treatment of Plaque Psoriasis in Adults (3002)
• PK, Safety and Tolerability Study of AVT02 (Adalimumab) Pre-filled Syringe (PFS) vs, AVT02 Autoinjector (AI)
• Iontophoresis in Psoriasis
• A Safety Study of CC-92252 in Healthy Adult Subjects and Adult Subjects With Psoriasis
• Oral Chinese Herbal Medicine for Psoriasis Vulgaris With Blood Heat Syndrome
• Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Single and Repeat Topical Administration of BOS-475 in Healthy Subjects and Patients With Psoriasis
• Tapinarof for the Treatment of Plaque Psoriasis in Adults (3001)
• A Clinical Observation on the Efficacy and Safety of Pulsed Dye Laser (PDL) in the Treatment of Nail Psoriasis
• Oral Chinese Herbal Medicine for Psoriasis Vulgaris With Blood Stasis Syndrome
• Chinese Herbal Medicine for Psoriasis Vulgaris: a Real World Study
• A Study of Ixekizumab (LY2439821) in Participants in Japan With Generalized Pustular Psoriasis and Erythrodermic Psoriasis
• Sequential Treatment of Psoriasis With Integrated Traditional Chinese and Western Medicine
• A Study of the Efficacy and Safety of Apremilast, in Subjects With Plaque Psoriasis That is Not Adequately Controlled by Topical Therapy
• An Investigational Study to Evaluate Experimental Medication BMS-986165 in Japanese Participants With Moderate-to-Severe Psoriasis
• A Study to Evaluate the Pharmacokinetics, Safety and Tolerability of ABBV-157 in Healthy Volunteers and in Participants With Chronic Plaque Psoriasis
• Studying the Effect of Methotrexate Alone Versus Methotrexate and Vitamin D on the Cardiovascular Risk of Psoriatic Patients
• Clinical Trial to Assess Safety, Tolerability and the Pharmacodynamics Effect of Calcipotriol/Betamethasone Dipropionate in a New Administration Form in Subjects With Chronic Plaque Psoriasis.
• Efficacy and Safety of Tildrakizumab in the Treatment of Scalp Psoriasis
• Efficacy and Safety Study of Tildrakizumab in the Treatment of Nail Psoriasis
• A Study to Evaluate Safety and Efficacy of PF-06826647 For Moderate To Severe Plaque Psoriasis
• A 5-year Study to Test BI 655130 in Patients With Generalized Pustular Psoriasis Who Took Part in Previous Studies With BI 655130
• To Evaluate the Therapeutic Equivalence and Safety in Treatment of Scalp Psoriasis
• A Study to Assess Usability of Risankizumab Autoinjector Combination Product in Participants With Moderate to Severe Plaque Psoriasis
• A Study to Assess Safety and Efficacy of Risankizumab Using a New Formulation in Participants With Moderate to Severe Plaque Psoriasis
• Combined Oral Vitamin D and UVB Versus UVB Alone in Treatment of Psoriasis Vulgaris
• Assessment of Gut Absorption of Experimental Medication BMS-986165 in Healthy Males
• A Study to Assess the Efficacy, Safety and Tolerability of KPL-716 in Reducing Pruritus in Chronic Pruritic Diseases
• Dose Ranging Study To Assess Efficacy, Safety and Tolerability Of PF-06700841 Topical Cream In Psoriasis
• The Effect of Enstilar Versus Vehicle on Target Lesions in Moderate Plaque Type Psoriasis Patients
• Efficacy and Safety of HAT1 Compared to Calcipotriol in Patients With Mild to Moderate Chronic Plaque Psoriasis
• Safety and Efficacy Study of DUR-928 Topical Solution in Subjects With Plaque Psoriasis
• A Study to Test How Well Patients With Plaque Psoriasis Tolerate BI 730357 Over a Longer Period and How Effective it is
• Study to Evaluate the Efficacy and Safety of JTE-451 in Subjects With Moderate to Severe Plaque Psoriasis
• Enstilar in Combination With Enbrel or Humira for Plaque Psoriasis
• A Maximal Use Trial Evaluating the Pharmacokinetic Profile of MC2-01 Cream in Adolescent Subjects
• A Study to Evaluate Further Therapeutic Strategies With Guselkumab in Participants With Moderate-to-Severe Plaque-Type Psoriasis
• Efficacy and Safety of LEO 90100 Foam in Japanese Subjects With Psoriasis Vulgaris
• This Trial is a Randomised, Multicentre, Investigator-blind, Vehicle and Comparator-controlled, Parallel-group Trial With the Purpose of Evaluation Efficacy, Safety and Convenience of the MC2-01 Cream
• Study to Assess the Safety and Tolerability of PBF-1650 in Healthy Volunteers.
• A Study to Test BI 655130 in Patients With a Flare-up of a Skin Disease Called Generalized Pustular Psoriasis
• An Efficacy and Safety Study of Apremilast (CC-10004) in Subjects With Moderate to Severe Genital Psoriasis
• A Study of the Impact of Apremilast (CC-10004) on Quality of Life, Efficacy, and Safety in Subjects With Manifestations of Plaque Psoriasis and Impaired Quality of Life
• A Study to Evaluate the Safe and Effective Use of the Prefilled Safety Syringe or the Auto-injector for the Subcutaneous Self-injection of Bimekizumab Solution by Subjects With Moderate to Severe Chronic Plaque Psoriasis (PSO)
• Clinical Research on Treatment of Psoriasis by Human Umbilical Cord-derived Mesenchymal Stem Cells
• Long-Term Safety of ARQ-151 Cream in Adult Subjects With Chronic Plaque Psoriasis
• A Comparison of 188-0551 Spray Versus Vehicle Spray in Subjects With Plaque Psoriasis
• A Study of EDP1815 in Healthy Participants and Participants With Mild to Moderate Psoriasis and Atopic Dermatitis
• To Study Generic Calcipotriene and Betamethasone Dipropionate Topical Foam, 0.005%/0.064%, in the Treatment of Psoriasis Vulgaris (Plaque Psoriasis).
• Comparison of 188-0551 Spray Versus Vehicle Spray in Subjects With Plaque Psoriasis (307)
• An Ascending Multiple Dose Study With VTP-43742 in Healthy Volunteers
• Apremilast as a Direct Treatment for Mild-to-moderate Plaque Psoriasis Versus Placebo: an Analysis of Clinical Safety and Efficacy
• A Study of Mirikizumab in Participants With Plaque Psoriasis
• A Real World Study Evaluating the Long-Term Quality of Life of Tildrakizumab in Adult Patients With Psoriasis
• Study to Evaluate Efficacy and Safety of MP1032 in Patients With Chronic Plaque Psoriasis
• Efficacy and Safety Study of Apremilast (CC-10004) in Pediatric Subjects From 6 Through 17 Years of Age With Moderate to Severe Plaque Psoriasis
• The Safety and Efficacy of a Novel HSP90 Inhibitor (CUDC-305) in the Treatment of Moderate to Severe Psoriasis.
• Clinical Trial to Assess Safety, Tolerability and the Pharmacodynamic Effect of Different Concentrations of a New Anti-inflammatory Substance in Subjects With Chronic Plaque Psoriasis
• Study to Assess the Long-term Safety, Tolerability, Efficacy of Secukinumab in Pediatric Patients of Age 6 to <18 Years, With Moderate to Severe Plaque Psoriasis
• Immunogenetic Profiling of Goeckerman Therapy in the Treatment of Psoriasis Vulgaris
• Nivolumab in Patients With Advanced Non-Small Cell Lung Cancer and Pre-existing Autoimmune Disease
• An Open-Label Study to Assess Safety
• The Safety, Efficacy and Pharmacokinetics of ARQ-151 Cream in Subjects With Chronic Plaque Psoriasis
• This Study is Done in Patients With Plaque Psoriasis and Tests How Well They Tolerate BI 730357 and How Effective it is
• A Study to Evaluate the Efficacy and Safety of ANB019 in Subjects With Palmoplantar Pustulosis
• A Study to Evaluate the Safety, Pharmacokinetics, and Efficacy of Topical ESR-114 in Subjects With Plaque Psoriasis
• Pain Outcomes Following Intralesional Corticosteroid Injections
• Metformin for Treatment of Psoriasis Combined With Disorders of Glucose and Lipid Metabolism
• Response to Ustekinumab for Anti-tnf Induced Psoriasiform Skin Lesions
• Safety and Pharmacokinetics of Sustained-release Depot Tacrolimus: A First-in-human Study
• Effectiveness and Safety of BMS-986165 Compared to Placebo and Active Comparator in Participants With Psoriasis
• A Study of AK111 in Healthy Subjects
• A Study to Evaluate the Efficacy and Safety of ANB019 in Subjects With Generalized Pustular Psoriasis
• A Study of PRCL-02 in Moderate to Severe Chronic Plaque Psoriasis
• An Investigational Study to Evaluate Experimental Medication BMS-986165 Compared to Placebo and a Currently Available Treatment in Participants With Moderate-to-Severe Plaque Psoriasis
• A Study to Evaluate the Efficacy and Safety of Bimekizumab in Adult Subjects With Moderate to Severe Chronic Plaque Psoriasis
• Evaluating the Efficacy and Tolerability of Application of Metaderm Product for the Treatment of Psoriasis
• Study of Efficacy and Safety of Secukinumab 2 mL Auto-injector (300 mg) in Subjects With Moderate to Severe Plaque Psoriasis
• Evaluation of Add on Enstilar in Patients Using Otezla for Psoriasis
• Role of Topical Treatments in the Modulation of Skin Microbiome in Psoriatic Skin
• A Food Effect Study to Assess Pharmacokinetics of Hemay005 in Healthy Volunteers
• A Study of Ixekizumab (LY2439821) Compared to Guselkumab in Participants With Moderate-to-Severe Plaque Psoriasis
• Multiple Ascending Dose Study to Assess Safety and Pharmacokinetics of Hemay005 In Healthy Subjects
• A Long-term Study to Evaluate Safety and Maintenance of Treatment Effect of LY3074828 in Participants With Moderate-to-Severe Plaque Psoriasis (OASIS-3)
• Apremilast Treatment for Pruritus and Quality of Life in Scalp Psoriasis
• A Study of EDP1066 in Healthy Participants and Participants With Mild to Moderate Psoriasis and Atopic Dermatitis
• Study of the Long Term Safety of Serlopitant for the Treatment of Pruritus (Itch)
• A Study to Evaluate the Efficacy and Safety of Bimekizumab Compared to an Active Comparator in Adult Subjects With Moderate to Severe Chronic Plaque Psoriasis
• A Study to Assess if Mirikizumab is Effective and Safe Compared to Secukinumab and Placebo in Moderate to Severe Plaque Psoriasis (OASIS-2)
• Risankizumab Therapy Versus Placebo for Subjects With Psoriasis in the Russian Federation
• Enstilar® Foam in the Treatment of Chronic Plaque Psoriasis in Patients With Skin of Color
• Efficacy and Safety of 2 Secukinumab Regimens in 90kg or More Weight Group With Moderate/Severe Chronic Plaque Psoriasis
• A Multiple Dose Study of BAY1834845 in Healthy Male Subjects and in Patients With Psoriasis
• A Study to Evaluate the Efficacy and Safety of Mirikizumab (LY3074828) in Participants With Moderate-to-Severe Plaque Psoriasis
• Risankizumab Versus Secukinumab for Participants With Moderate to Severe Plaque Psoriasis
• Effect of Brodalumab Compared to Placebo on Vascular Inflammation in Moderate-to-severe Psoriasis
• Safety, Tolerability And Efficacy Study Of Topical PF-06763809 In Subjects With Mild To Moderate Chronic Plaque Psoriasis
• Multi-Dose Study of SHR-1314 in Subjects With Moderate-to-severe Plaque Psoriasis
• A Maximal Use Trial Evaluating the Pharmacokinetic Profile of MC2-01 Cream
• A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Subcutaneously Administered Guselkumab for the Treatment of Chronic Plaque Psoriasis in Pediatric Participants
• Safety, Tolerability and Efficacy of SNA-120 for Treatment of Pruritus and Psoriasis in Subjects Treated With Calcipotriene
• A Study Assessing the PK, PD, Safety, and Tolerability of SB414 in Psoriasis
• Skin Irritation of LEO 90100 Foam (Calcipotriol Hydrate Plus Betamethasone Dipropionate) in Healthy Japanese Subjects
• Monocyte Biomarkers in Moderate to Severe Plaque Psoriasis Subjects Treated With Apremilast
• Efficacy and Safety of Enstilar Foam in Combination With Apremilast (Otezla) in Patients With Moderate Plaque Psoriasis
• Comparison of Secukinumab 300 mg Combined With a Lifestyle Intervention to Secukinumab Alone for the Treatment of Moderate to Severe Psoriasis Patients With Concomitant Metabolic Syndrome
• Once-Weekly Oral Aminopterin for the Treatment of Subjects With Moderate-To-Severe Psoriasis
• Safety and Efficacy of UC-MSCs in Patients With Plaque Psoriasis
• A Study to Assess the Efficacy and Safety of PPC-06 (Tepilamide Fumarate)
• An Investigational Study of Cyclosporine on Experimental Medication BMS-986165 in Healthy Male Participants
• A Study of LY3316531 in Healthy Participants and in Participants With Psoriasis
• A Study to Evaluate the Efficacy and Safety of Bimekizumab in Adult Subjects With Moderate to Severe Chronic Plaque Psoriasis
• A Study With a Initial Treatment Period Followed by a Randomized-withdrawal Period to Evaluate the Efficacy and Safety of Bimekizumab in Adult Subjects With Moderate to Severe Chronic Plaque Psoriasis
• Comparison of Oral Versus Subcutaneous Route of Methotrexate Administration in Moderate to Severe Psoriasis
• A Study to Determine the Safety and Sensitizing Potential of HAT1 Topical Products Using Skin Sensitivity Patch Tests
• Brodalumab in Subjects With Moderate to Severe Plaque Psoriasis Who Have Failed IL-17A Therapies
• 1404003_OpenPsori.PlaqueTest to Eval.Eff.of Diff.Comp. to Mapracorat
• Efficacy and Safety of AD-MSCs Plus Calpocitriol Ointment in Patients With Moderate to Severe Psoriasis
• Safety, Pharmacokinetics and Efficacy of ARQ-151 Cream in Adults With Mild to Moderate Chronic Plaque Psoriasis
• An International Multicenter, Randomized, Double-blind, Placebo-Controlled Clinical Study of Efficacy and Safety of Two Dosing Regimens of BCD-085 (JSC BIOCAD, Russia) in Patients With Moderate to Severe Plaque Psoriasis
• A Phase 2b Study of the Efficacy, Safety, and Tolerability of M1095 (Sonelokimab) in Subjects With Moderate to Severe Psoriasis
• Topical Application of BMX-010 in Subjects With Atopic Dermatitis and Plaque Psoriasis
• Efficacy and Safety of TC Cream In Treating Patients With Psoriasis Vulgaris
• A Study to Evaluate the Efficacy and Safety of Bimekizumab Compared to Placebo and an Active Comparator in Adult Subjects With Moderate to Severe Chronic Plaque Psoriasis
• A Study of Ixekizumab (LY2439821) in Chinese Participants With Moderate-to-Severe Plaque Psoriasis
• Study to Evaluate the Safety and Efficacy of JTE-051 in Subjects With Moderate to Severe Plaque Psoriasis
• Formulation and Clinical Evaluation of Ethosomal and Liposomal Preparations of Anthralin in Psoriasis
• Study of the Efficacy, Safety and Tolerability of Serlopitant for the Treatment of Pruritus (Itch) With Plaque Psoriasis
• AGN-242428 in the Treatment of Plaque Psoriasis
• Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of CC-90006 in Subjects With Mild to Moderate Plaque-type Psoriasis
• The Effect of Vitamin D Supplementation on Psoriasis Severity
• A Trial Comparing the Efficacy of Subcutaneous Injections of Brodalumab to Oral Administrations of Fumaric Acid Esters in Adults With Moderate to Severe Plaque Psoriasis
• To Study Generic Calcipotriene and Betamethasone Dipropionate Topical Suspension, 0.005%/0.064%, in the Treatment of Scalp Psoriasis
• A Study of Experimental Medication BMS-986251, Taken by Mouth, in Healthy Participants and Patients With Average to Very Serious Psoriasis
• Safety, Efficacy, and Tolerability of SNA-120 in Subjects With Pruritus Associated With Psoriasis Vulgaris
• Study of Efficacy and Safety of HLX03 in Subjects With Moderate to Severe Plaque Psoriasis
• Study to Determine if AZD0284 is Effective and Safe in Treating Plaque Psoriasis
• A Clinical Trial Evaluating Efficacy and Safety of MC2-01 Cream
• Secukinumab Therapy for the Treatment of Moderate to Severe Plaque Psoriasis With Response Monitoring Using Optical Coherence Tomography (OCT).
• Multiple-Dose Pharmacokinetics and Potential for Adrenal Suppression Following Treatment With Halobetasol Spray in Patients With Plaque Psoriasis
• This Study Tests How Healthy Men Tolerate Different Doses of BI 730357 and How the Metabolism of Midazolam is Affected by BI 730357
• Efficacy of Combined Fractional Carbon Dioxide Laser and Topical Tazarotene in the Treatment of Psoriatic Nail Disease
• The Effect of BMS-986165 Combined With an Oral Contraceptive (Ethinyl Estradiol/Norethindrone) in Healthy Female Patients
• A Study to Assess the Efficacy of Risankizumab Compared to FUMADERM® in Subjects With Moderate to Severe Plaque Psoriasis Who Are Naïve to and Candidates for Systemic Therapy
• A Study to Evaluate BMS-986165 Tablet Formulation Relative to BMS-986165 Capsule Formulation and the Effect of a High-Fat/ High-Calorie Meal and Increased Gastric pH on the BMS-986165 Tablet Formulation
• Multiple Dose Study With Incremental Dosing to Evaluate the Safety, Tolerability, and Pharmacokinetics of Oral Doses of LEO 32731 in Healthy Male Japanese Subjects.
• A Study to Evaluate the Long-term Safety, Tolerability and Efficacy of Bimekizumab in Adult Patients With Chronic Plaque Psoriasis
• Study of Icotinib Hydrochloride Cream in Patients With Mild to Moderate Psoriasis
• A Study Comparing the Safety and Efficacy of Risankizumab to Methotrexate in Subjects With Moderate to Severe Plaque Psoriasis
• MAP Study: Methotrexate and Adalimumab in Psoriasis
• Evaluation of Adrenal Suppression Potential and Pharmacokinetics of Halobetasol Lotion 0.05%
• A First in Human Study to Evaluate Safety, Tolerability, and Pharmacology of PF-06826647 in Healthy Subjects and Subjects With Plaque Psoriasis
• The VOLTAIRE-X Trial Looks at the Effect of Switching Between Humira® and BI 695501 in Patients With Plaque Psoriasis
• Study to Evaluate the Efficacy and Safety of P-3073 Nail Solution in the Treatment of Mild to Moderate Psoriatic Fingernail/s
• GSK2894512 Vehicle-Controlled Study for Adult Plaque Psoriasis
• A Study to Evaluate Pharmacokinetic (PK), Safety and Tolerability of GSK2894512 in Healthy Adult Subjects
• Assessment of the Clinical and Ultrasound Response to Apremilast by Clinical Evaluation and by a Joint-periarticular-nail Ultrasound Index in Patients With Active Psoriatic Arthritis
• Assess the Potential for Adrenal Suppression and Systemic Drug Absorption Following Multiple Dosing With DFD-06
• CF101 Therapy in Patients With Moderate-to-severe Plaque Psoriasis
• A Study of KY1005 in Healthy Volunteers
• Climatotherapy Versus Topical Combination of Corticosteroids and Salicylic Acid in Treatment of Psoriasis
• Analysis of the Pathogenesis of Itch in Response to Apremilast Therapy in Psoriasis Patients
• A Study to Evaluate the Pharmacokinetics, Safety and Tolerability of ABBV-553 in Healthy Volunteers and in Subjects With Psoriasis and Efficacy of ABBV-553 in Subjects With Psoriasis
• Initial Dosing of BI 655130 in Palmoplantar Pustulosis Patients
• Safety and Efficacy of Secukinumab in Mild Psoriasis
• A Study of the Efficacy and Safety of Apremilast (CC-10004) in Subjects With Moderate to Severe Plaque Psoriasis of the Scalp
• BE Study of Calcipotriene Hydrate and Betamethasone Dipropionate Topical Suspension in the Treatment of Scalp Psoriasis
• A Study to Evaluate the Comparative Efficacy of CNTO 1959 (Guselkumab) and Secukinumab for the Treatment of Moderate to Severe Plaque-type Psoriasis
• Vascular Inflammation in Psoriasis - Apremilast
• Enstilar in Combination With Biologic Agents
• Study to Evaluate the Efficacy and Safety of P-3073 Nail Solution in the Treatment of Mild to Moderate Psoriatic Fingernail/s
• A Study of Ixekizumab in Chinese Participants With Psoriasis Vulgaris
• Study of Ixekizumab (LY2439821) in Children 6 to Less Than 18 Years With Moderate-to-Severe Plaque Psoriasis
• Study of Efficacy and Safety of Secukinumab in Subjects With Moderate to Severe Chronic Plaque-type Psoriasis
• A Comparison of 188-0551 Solution Versus Vehicle Solution in Subjects With Plaque Psoriasis (Study 203)
• A Study of PRCL-02 in Healthy Volunteers and Plaque Psoriasis
• Topically Applied IDP-118 Lotion and HP Monad Lotion in Subjects With Moderate to Severe Plaque Psoriasis
• A Study to Test the Efficacy and Safety of Certolizumab Pegol in Japanese Subjects With Moderate to Severe Chronic Psoriasis
• Evaluating Treatment Resistant Dermatitis TaroIIR
• A Study to Evaluate the Pharmacokinetics (PK), Pharmacodynamics (PD), and Safety of Bimekizumab in Patients With Chronic Plaque Psoriasis
• Safety and Efficacy of CD10367 in Psoriasis Vulgaris
• An Investigator Initiated Open Label Study Evaluating the Efficacy and Tolerability of Oral Apremilast for the Treatment of Nail Psoriasis
• A Study to Assess Efficacy and Safety of Two Different Dose Regimens of Risankizumab Administered Subcutaneously in Japanese Subjects With Generalized Pustular Psoriasis or Erythrodermic Psoriasis
• Study of the Efficacy of Early Intervention With Secukinumab 300 mg s.c. Compared to Narrow-band UVB in Patients With New-onset Moderate to Severe Plaque Psoriasis
• Study to Evaluate Safety,Tolerability,Pharmacodynamics & Pharmacokinetics of JTE-451 in Active Plaque Psoriasis Subjects
• A Study to Evaluate the Long-term Safety, Tolerability and Efficacy of Bimekizumab in Patients With Chronic Plaque Psoriasis
• Safety and Pharmacokinetics of Hemay005 In Healthy Male Subjects
• Safety and Efficacy Study Comparing AM001 Cream, 7.5% to Vehicle Cream in the Treatment of Plaque Psoriasis
• A Study of GSK2981278 Ointment in Subjects With Plaque Psoriasis
• Pharmacokinetics and Metabolism of [14C]BMS-986165 in Healthy Male Participants
• Trial to Assess the Potency of SOR007 Ointment in a Psoriasis Plaque Test
• A Trial of a Botanical Drug (EISO) for Treatment of Mild-to-Moderate Plaque Psoriasis
• Use of Apremilast in Patients Who Are Dissatisfied With Stable Maintenance Topical Therapy
• BI 655066 (Risankizumab) Compared to Placebo in Japanese Patients With Moderate to Severe Chronic Plaque Psoriasis
• Efficacy and Safety Study of NP000888 in Subjects With Plaque and Nail Psoriasis
• A Study of Ixekizumab in Participants With Plaque Psoriasis
• A Trial of a Botanical Drug Containing East Indian Sandalwood Oil (EISO) for Treatment of Plaque Psoriasis in Adults
• Topical Scalp Psoriasis Study Evaluating Topicort Topical Spray
• Topical Psoriasis Study for Patients Receiving Biologic Therapy
• A Study of KHK4827 (Brodalumab) in Subjects With Moderate to Severe Psoriasis in Korea
• BI655130 Single Dose in Generalized Pustular Psoriasis
• Study to Assess the Safety, Tolerability and Pharmacokinetics and Pharmacodynamics of AZD0284 in Healthy Subjects
• A Phase I, Double Blind, Randomized, Placebo Controlled, Maximal Dose Study to Determine the Safety, Tolerability of Topical Cream Containing MGC (Medical Grade Cannabis) in Healthy Volunteers
• Vasoconstriction Trial With LEO 90100 Aerosol Foam
• A Phase 2, Multicenter, Open-label Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Pefcalcitol Ointment, 0.005%, Applied Topically Twice Daily (BID) for 8 Weeks in Adolescent Subjects 12 to < 17 Years of Age With P
• Study To Evaluate Safety And Efficacy Of PF-06700841 In Subjects With Moderate To Severe Plaque Psoriasis
• Study of the Effects of the Organism on Monomethyl Fumarate (MMF) After the Administration of LAS41008
• APremilast After FumaRic Acid Ester Treatment
• A Study to Compare the Efficacy of Guselkumab to Fumaric Acid Esters for the Treatment of Participants With Moderate to Severe Plaque Psoriasis
• Efficacy and Safety of Prurisol Administered Orally for Active Moderate to Severe Chronic Plaque Psoriasis
• BE Study in Patients - Methotrexate Tablets
• BAY1003803 Formulation Comparison in Open Psoriasis Plaque Test
• BAY1003803 Single and Multiple Dose Escalation, Safety, Tolerability and Pharmacokinetics Study
• PSOREAL - Managing PSOriasis in the REAL World
• A Study of SHR-1314 in Healthy Subjects
• Phase III Clinical Study in Patients With Mild to Severe Scalp Psoriasis
• Safety Study to Assess the Potential for Adrenal Suppression Following Maximal Use Treatment With DSXS
• Safety Study in Patients With Scalp Psoriasis Suppression Following Maximal Use Treatment With Topical Product
• An Open Label, Safety Study to Assess the Potential for Adrenal Suppression
• Study to Evaluate Efficacy and Safety of the Topical Product in Patients With Mild to Severe Scalp Psoriasis
• Study to Evaluate Effectiveness and Safety in Subjects With Moderate to Severe Psoriasis
• Incidence of Hospitalizations for Serious Infections in Patients Receiving Biologic Anti-Inflammatories for Rheumatologic, Psoriatic, and Gastrointestinal Conditions: A Descriptive Analysis
• Study to Evaluate Safety and Efficacy of Oral MP1032 in Psoriasis Patients
• Efficacy and Safety Study of Guselkumab in the Treatment of Participants With Moderate to Severe Plaque-Type Psoriasis
• Study to Evaluate Safety and Efficacy of Different Doses of Bimekizumab in Patients With Chronic Plaque Psoriasis
• Trial in Patients With Psoriasis Treated With Methotrexate Using an Optimized Treatment Schedule (METOP)
• A Study of Mirikizumab (LY3074828) in Participants With Moderate to Severe Plaque Psoriasis
• LEO 90100 Twice Weekly Maintenance Regimen for Psoriasis Vulgaris
• A Study of LY3041658 in Participants With Skin Diseases
• LEO 32731 for the Treatment of Moderate to Severe Psoriasis Vulgaris
• A Study Comparing Tazarotene Cream 0.05% to TAZORAC® (Tazarotene) Cream 0.05% and Both to a Placebo Control in the Treatment of Plaque Psoriasis
• Efficacy and Tolerability of Enstilar® in Daily Practice
• An Efficacy and Safety Study of LYC-30937-EC in Subjects With Moderate Chronic Plaque-type Psoriasis
• Adherence in Topical Treatment of Psoriasis
• Real-life Evaluation of the Daivobet® Gel Applicator
• A Phase 2, Double-blind, Placebo-controlled Study of the Efficacy and Safety of Belumosudil in Subjects With Moderate/Severe Chronic Plaque Psoriasis
• Efficacy, Safety and Immunogenicity of BI 695501 Versus Humira® in Patients With Moderate to Severe Chronic Plaque Psoriasis
• Multicenter Randomized Double Blind Controlled-study to Assess the Potential of Methotrexate Versus Placebo to Improve and Maintain Response to Anti TNF- Alpha Agents in Adult Patients With Moderate to Severe Psoriasis
• Study of Secukinumab Compared to Ustekinumab in Subjects With Plaque Psoriasis
• Icotinib Hydrochloride Cream in Patients With Mild to Moderate Psoriasis
• TAB08 in Patients With Psoriasis Vulgaris, Not Adequately Controlled With Current Treatment
• Assessment of Efficacy and Safety of Secukinumab in Adult Patients in Turkish Population
• Safety and Efficacy of IDP-122 Lotion When Applied Topically to Subjects With Moderate to Severe Plaque Psoriasis
• Safety and Efficacy of IDP-118 Lotion to Ultravate® in the Treatment of Plaque Psoriasis
• Safety and Efficacy of IDP-118 Lotion in the Treatment of Plaque Psoriasis
• Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of Repeat Doses of GSK2982772 in Subjects With Psoriasis
• Apremilast Pregnancy Exposure Registry
• This Study Tests the Effect of Risankizumab on the Metabolism in the Liver of Five Additional Drugs to Study Possible Drug Interactions in Patients With Psoriasis With or Without Psoriatic Arthritis
• Safety Study of BMS-986202 in Healthy Subjects and to Treat Psoriasis
• International Clinical Trial to Evaluate Efficacy and Safety of Multiple Subcutaneous Injections of BCD-085 in Various Doses in Patients With Moderate to Severe Plaque Psoriasis
• A Phase I Study With LEO 32731 and Midazolam in Healthy Male Subjects
• A Study to Evaluate Clear Skin Effect on Quality of Life in Patients With Plaque Psoriasis.
• Patient Satisfaction Following Twice Daily Dosing With DFD-01 in Subjects With Moderate Plaque Psoriasis
• Efficacy and Safety of 0.25% Desoximetasone Cream (Topoxy®) in the Treatment of Scalp Psoriasis
• Study to Evaluate the Efficacy of Etanercept Treatment in Adults Who Failed Therapy With Apremilast
• Study of Secukinumab With 2 mL Pre-filled Syringes
• A Comparison of 122-0551 Foam Versus Vehicle Foam in Subjects With Plaque Psoriasis (Study 310)
• Efficacy and Safety of Blue Light (453 nm) Treatment for Mild Psoriasis Vulgaris Over Three Months Compared to Vitamin D.
• A Trial That Compound Clobetasol Propionate Ointment Treats Patients With Mild to Moderate Psoriasis Vulgaris.
• Glucocorticoid-induced Osteoporosis in Patients With Chronic Inflammatory Rheumatic Diseases or Psoriasis
• A Study of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Genital Psoriasis
• Pharmacogenomics Study on Treatment of Psoriasis Vulgaris by Acitretin Capsules
• Pharmacogenomics Study on Treatment of Psoriasis Vulgaris by Methotrexate
• Safety and Efficacy Study of Etanercept (Qiangke®) to Treat Moderate to Severe Plaque Psoriasis
• An Efficacy, Safety, and Pharmacokinetics Study of Subcutaneously Administered Ustekinumab in the Treatment of Moderate to Severe Chronic Plaque Psoriasis in Pediatric Participants Greater Than or Equal to 6 to Less Than 12 Years of Age
• Trial Twice Daily Application of LEO 124249 Ointment 30 mg/g in Treatment of Mild to Moderate Inverse Psoriasis
• BI 655066/ABBV-066 (Risankizumab) Compared to Active Comparator (Adalimumab) in Patients With Moderate to Severe Chronic Plaque Psoriasis
• The Difference of Microparticles in Patients With Psoriasis Vulgaris Who Received Stelara(Ustekinumab)
• Study to Evaluate the Effect of Secukinumab Compared to Placebo on Aortic Vascular Inflammation in Subjects With Moderate to Severe Plaque Psoriasis
• A Study to Investigate the Safety, Tolerability and Pharmacokinetics of ABY-035
• BI 655066 (Risankizumab) Compared to Placebo and Active Comparator (Ustekinumab) in Patients With Moderate to Severe Chronic Plaque Psoriasis
• BI 655066 Versus Placebo & Active Comparator (Ustekinumab) in Patients With Moderate to Severe Chronic Plaque Psoriasis
• BI 655066 / ABBV-066 (Risankizumab) in Moderate to Severe Plaque Psoriasis With Randomized Withdrawal and Re-treatment
• LEO 80185 Gel (Calcipotriol Hydrate Plus Betamethasone Dipropionate) in Japanese Subjects With Psoriasis
• MSB11022 in Moderate to Severe Chronic Plaque Psoriasis
• Comparison Study of Psoriasis Severity Assessment Tools
• Assessing the Efficacy and Safety of Metformin in Treatment of Moderate Psoriasis
• An Efficacy and Safety of Guselkumab in Participants With Palmoplantar Pustulosis
• Xamiol®Gel in BODY Psoriasis: A One-year Non-interventional Study
• A Study of the Efficacy and Safety of DFD-06 Cream in the Treatment of Moderate to Severe Plaque Psoriasis
• A Study of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque Psoriasis Naive to Systemic Treatment
• Multiple Ascending Dose Study of PRX003 in Subjects With Psoriasis
• Proton Pump Inhibitors Use in Patients With Psoriasis
• The Effect of Riboflavin on Moderate to Severe Plaque Type Psoriasis
• Clinical Study to Evaluate the Efficacy and Safety of DSXS in Patients With Mild to Moderate Plaque Psoriasis
• A Study to Determine the Efficacy of ZPL-3893787 in Subjects With Plaque Psoriasis
• Investigate Effect of Secukinumab on the PK of Midazolam in Patients With Mod to Sev Plaque Psoriasis
• Study to Evaluate the Efficacy and Safety of P-3073 Nail Solution in the Treatment of Nails Affected by Psoriasis
• Dermatopharmacokinetic Trial of LEO 80185 Gel
• Study to Assess the Potential for Adrenal Suppression Following Treatment With DSXS in Patients With Plaque Psoriasis
• Study to Evaluate Psoriasis Severity and Its Psychosocial Impact Using the Simplified Psoriasis Index (SPI), as Well as Long-term Safety, Tolerability and Efficacy of Secukinumab Administered Subcutaneously in Patients With Moderate to Severe Psoria
• Immunologic Response to Secukinumab in Plaque Psoriasis
• An Exploratory Trial Investigating the Neurogenic Component in Psoriasis Vulgaris by Use of Botulinum Toxin A
• A Study of Safety, Tolerability and Pharmacokinetics of Apremilast (CC-10004) in Pediatric Subjects With Moderate to Severe Plaque Psoriasis
• Icotinib Hydrochloride Cream in Healthy Adults and Psoriasis Patients
• A Dose-Finding Study of GSK2894512 Cream in Subjects With Plaque Psoriasis
• A Study of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque Psoriasis
• Evaluation of Cardiovascular Risk Markers in Psoriasis Patients Treated With Secukinumab
• A Phase 4 Study of Efficacy and Safety of Apremilast in Subjects With Moderate Plaque Psoriasis.
• An Ascending Multiple Dose Study With VTP-43742 in Healthy Volunteers and Psoriatic Patients
• Clinical Utility Of Genetic Screening For HLA-B*1301, On Susceptibility To Dapsone Hypersensitivity Syndrome
• Study of Safety and Efficacy of Topical GSK2981278 Ointment in Plaque Psoriasis
• Open-label Study of Subcutaneous Secukinumab to Evaluate Efficacy and Safety in Patients With Plaque Psoriasis Who Had Inadequate Response to Cyclosporine A
• Safety and Effectiveness of Live Zoster Vaccine in Anti-Tumor Necrosis Factor (TNF) Users (VERVE Trial)
• Safety and Effectiveness of Live Zoster Vaccine in Anti-Tumor Necrosis Factor (TNF) Users (VERVE Trial)
• Safety Study of BMS-986165 in Healthy Subjects and to Treat Psoriasis
• Long-term Treatment of Scalp Psoriasis With Xamiol® Gel in a Large Adult Chinese Population
• Study to Investigate Efficacy and Safety of Adalimumab in Japanese Subjects With Generalized Pustular Psoriasis (GPP)
• A Study to Assess the Safety, Pharmacokinetics and Pharmacodynamics of UCB4940 in Patients With Psoriasis
• DFD01 Spray HPA Axis Suppression Study in Adolescent Patients With Moderate to Severe Plaque Psoriasis
• A Psoriasis Plaque Test Trial With LEO 90100 Compared to Betesil® in Patients With Psoriasis Vulgaris
• Safety and Efficacy of IDP-122 in the Treatment of Participants With Plaque Psoriasis
• LEO 32731 - A Phase I Study in Healthy Subjects
• Safety and Efficacy of IDP-122 in the Treatment of Participants With Plaque Psoriasis
• A Study Comparing Different Dosing Regimens of Ixekizumab (LY2439821) in Participants With Moderate to Severe Plaque Psoriasis
• Phase 1 Study of CC-90005 in Healthy Subjects and Subjects With Moderate to Severe Plaque-type Psoriasis
• Efficacy and Safety of Prurisol Administered Orally for Active Mild to Moderate Chronic Plaque Psoriasis
• Comparison of CHS-1420 Versus Humira in Subjects With Chronic Plaque Psoriasis
• A Long Term Safety Extension Study (CHS-0214-05)
• A Study To Evaluate The Efficacy Of Enbrel (REGISTERED) Etanercept Over A Period Of 12 Months In The Routine Treatment Of Patients With Rheumatoid Arthritis, Axial Spondyloarthritis, Psoriatic Arthritis, Or Plaque Psoriasis.
• Psoriasis-Arthritis & Bone Program
• Study of Secukinumab Compared to Fumaderm® in Adults With Moderate to Severe Psoriasis.
• Secukinumab Dosage Optimisation in Partial Responders With Moderate to Severe Plaque-type Psoriasis
• Psoriatic Arthritis Treated With Liraglutide Therapy: a QUality of Life and Efficacy Study
• Safety and Efficacy of IDP-118 in the Treatment of Plaque Psoriasis
• Long-Term Safety of IDP-118 Lotion in the Treatment of Plaque Psoriasis
• Safety and Efficacy of IDP-118 in the Treatment of Plaque Psoriasis
• Single Ascending Dose Study of PRX003 in Healthy Subjects
• A Study of the Efficacy and Safety of DFD-06 Cream in the Treatment of Moderate to Severe Plaque Psoriasis
• A 4 Week Study of the Safety, Tolerability, and Pharmacodynamics of ShK-186 (Dalazatide) in Active Plaque Psoriasis
• Efficacy of Atorvastatin as Adjunctive Treatment for Chronic Plaque Type Psoriasis
• Trial to Evaluate Topical C-82 in a Psoriasis Plaque Test
• A Phase 4 Study of Efficacy and Safety of Apremilast in Subjects With Moderate Plaque Psoriasis.
• A Psoriasis Plaque Test Trial With LP0113 Spray in Patients With Psoriasis Vulgaris (LP0113-1123)
• A Randomized Double Blind Vehicle Controlled Dose Ranging Parallel Design Multiple Site Clinical Study
• Apremilast 30mg Bid With Narrowband UVB in the Treatment of Plaque Psoriasis
• Varicella Zoster Vaccine in Patients With Plaque Psoriasis Treated With Biologic Therapy
• An Open-Label, Phase 2a Study to Evaluate Safety and Efficacy of GR-MD-02 for Treatment of Psoriasis
• Apremilast in Palmo-Plantar Psoriasis
• Pharmacokinetic Study to Evaluate the Effect of a Single Dose of Guselkumab (CNTO 1959) on CYP 450 Enzyme Activities After Subcutaneous Administration in Participants With Psoriasis
• Safety and Efficacy of Once Daily Topical Treatment With LEO 90100 Aerosol Foam in Adolescent Subjects With Plaque Psoriasis
• A Study of the Early Activity of Ixekizumab (LY2439821) in Moderate-to-Severe Psoriasis
• On the Impact of Therapeutic Tumor Necrosis Factor-alpha Inhibition on Anogenital Human Papillomavirus Infection
• A Comparison of 122-0551 Foam Versus Vehicle Foam in Subjects With Plaque Psoriasis (Study 306)
• A Comparison of 122-0551 Foam Versus Vehicle Foam in Subjects With Plaque Psoriasis
• Dipeptidyl Peptidase-4 Inhibition and Narrow-band Ultraviolet-B Light in Psoriasis (DINUP)
• An Efficacy and Safety Study of CNTO1959 (Guselkumab) in the Treatment of Participants With Generalized Pustular Psoriasis or Erythrodermic Psoriasis
• Adrenal Suppression and Pharmacokinetics of Topicort® Spray, 0.25% in Pediatric Patients With Plaque Psoriasis
• Comparative Effectiveness of Psoriasis Treatments on Systemic Inflammation
• Natural Gels for Treatment of Plaque Psoriasis
• An Efficacy and Safety of CNTO 1959 (Guselkumab) in Participants With Moderate to Severe Plaque-type Psoriasis
• An Observational Monocentric Study Investigating the Association Between Trough Serum Levels of Etanercept, Antibodies Towards Etanercept and Its Effectiveness in Psoriasis Patients
• A Phase 2 Study of Cellular and Immunologic Changes in the Skin of Subjects Receiving PH-10
• Phase 2, Open-label, Study of KD025 in Subjects With Psoriasis Vulgaris Who Failed First-line Therapy
• Optimizing Psoriasis Treatment of Etanercept Combined Methotrexate
• A Safety, Tolerability, Pharmacokinetics And Pharmacodynamics Study Of PF-06700841, With Bioavailability/Food Effect Investigation
• Patient Insights Following Use of LEO 90100 Aerosol Foam and Daivobet® Gel in Subjects With Psoriasis Vulgaris
• Study to Assess Safety, Tolerability, Pharmacokinetic & Pharmacodynamic Effect of UCB5857 in Healthy & Psoriatic Subject
• A Study to Evaluate Safety and Efficacy of Toreforant (JNJ-38518168) in Participants With Moderate to Severe Plaque-type Psoriasis
• Study to Assess the Immunogenicity and Safety of Etanercept Produced Using a Modified Process in Patients With Plaque Psoriasis
• Safety and Efficacy of Etanercept in Patients With Psoriasis
• Quality of Life of Patients With Psoriasis Treated With Methotrexate: Prospective, Randomized, Double-blind, Parallel Group Study.
• Safety and Tolerability Study of COVA322 in Patients With Stable Chronic Moderate-to-severe Plaque Psoriasis
• Efficacy and Safety of Tazarotene Gel in Nail Psoriasis
• BIRB 796 BS Versus Placebo in Patients With Moderate to Severs Plaque-type Psoriasis
• A Study of Guselkumab in the Treatment of Participants With Moderate to Severe Plaque-Type Psoriasis With Randomized Withdrawal and Retreatment
• A Study of Guselkumab in the Treatment of Participants With Moderate to Severe Plaque-Type Psoriasis
• Extension Trial Assessing the Safety and Efficacy of BI 655066/ABBV-066/Risankizumab in Patients With Moderate to Severe Chronic Plaque Psoriasis
• A Study of Guselkumab in Participants With Moderate to Severe Plaque-type Psoriasis and an Inadequate Response to Ustekinumab
• Study to Evaluate PF-04965842 in Patients With Moderate to Severe Psoriasis
• Concomitant Longitudinal Evaluation of Adalimumab With Methotrexate in the Real World: the CLEAR Study
• A 12 Day Study To Evaluate A Topical Drug To Treat Plaque Psoriasis
• Efficacy and Safety Study of Total Glucosides of Paeony Combined With Acitretin to Treat Psoriasis
• Efficacy and Safety Study of Calcipotriol Betamethasone Plus Calcipotriol in Sequential Therapy to Psoriasis
• Vascular Inflammation in Psoriasis-Ustekinumab (VIP-U)
• Plaque Psoriasis Study in Pediatric Subjects
• A Intra-individual Comparison to Investigate the Efficacy and the Safety of LAS41004 Formulation in Mild to Moderate Psoriasis
• A Bioequivalence Study Comparing a Single 1.5mL Dose of Brodalumab vs. Two Doses (1.0mL + 0.5mL) of Brodalumab
• A Study to Assess the Efficacy and Safety of XP23829 in Subjects With Moderate-to-Severe Chronic Plaque-Type Psoriasis
• Generic Tazarotene Cream, 0.05% for the Treatment of Plaque Psoriasis
• Multiple Ascending Dose Trial of MSB0010841 (Anti-IL17A/F Nanobody) in Psoriasis Subjects
• An Exploratory Genetic Study in Participants With Psoriasis
• Clinical Trial of PSORI-CM01（YXBCM01） Granule to Treat Stable Plaque Psoriasis
• The NOR-SWITCH Study
• Effects of Treatment With Biological Agents on Vascular and Cardiac Function in Psoriasis
• Comparison of CHS-0214 to Enbrel (Etanercept) in Patients With Chronic Plaque Psoriasis (PsO)
• LEO 90100 Aerosol Foam Compared to Calcipotriol Plus Betamethasone Dipropionate Gel in Subjects With Psoriasis Vulgaris
• DFD06 Cream vs Clobetasol Propionate Cream, 0.05% Hypothalamic- Pituitary-Adrenal (HPA) Axis Suppression Study in Patients With Moderate to Severe Plaque Psoriasis
• Efficacy and Safety of Namilumab (MT203) for Plaque Psoriasis
• LP0058-1005 - A Open-Label, Four-Way Crossover and Food-Effect Study of LEO 32731 in Healthy Subjects
• Long Term Safety and Efficacy Study of Calcitriol 3 mcg/g Ointment in Pediatric Subjects With Plaque Psoriasis
• ASIS for Enbrel in Plaque Psoriasis
• Efficacy, Tolerability and Safety of LAS41004 Formulations in a Psoriasis Plaque Test
• A Safety and Tolerability Study of Belumosudil (KD025) Treatment in Subjects With Moderately Severe Psoriasis Vulgaris
• Bioequivalence and Pharmacokinetic Study of Prurisol™ and Abacavir Sulfate in Healthy Volunteers
• Bioavailability in Patient With Psoriasis: Metoject Prefilled Pen
• Mechanistic Study of Indigo Naturalis in Treating Psoriasis
• Study to Evaluate Product Duration of Use Experience With Alclometasone Dipropionate Cream
• Efficacy of Secukinumab Compared to Ustekinumab in Patients With Plaque-type Psoriasis
• DFD01 Spray vs Comp01 Lotion HPA Axis Suppression Study in Patients With Moderate to Severe Plaque Psoriasis
• BI 655066 Dose Ranging in Psoriasis, Active Comparator Ustekinumab
• A Phase 3 Clinical Study of KHK 4827
• Safety and Efficacy of IDP 118 in the Treatment of Plaque Psoriasis
• An International, Multi-centre, Prospective, Non-controlled, Open, Single-group, 8-week Trial in Adolescent Subjects
• Study to Demonstrate Equivalent Efficacy and to Compare Safety of Biosimilar Adalimumab (GP2017) and Humira
• Palmoplantar Pustular Psoriasis Efficacy and Safety wIth Secukinumab
• Study for Treatment With Calcipotriol/Betamethasone Dipropionate Gel in Korean Patients With Psoriasis Vulgaris
• Efficacy of Ustekinumab Followed by Abatacept for the Treatment of Psoriasis Vulgaris
• A Safety and Efficacy Study of DRM02 in Subjects With Plaque Psoriasis
• Dipeptidyl Peptidase-4 Inhibition in Psoriasis Patients With Diabetes (DIP): A Randomized Clinical Trial.
• Etanercept and Vascular Function in Psoriasis
• Efficacy Study Comparing Topical M518101 and Vitamin D3 in Adult Psoriasis Patients
• Induction of Regulatory t Cells by Low Dose il2 in Autoimmune and Inflammatory Diseases
• Efficacy and Safety Study of Two Doses of Apremilast (CC-10004) In Japanese Patients With Moderate-To-Severe Plaque-Type Psoriasis
• Dose-finding Study of MT-1303 in Subjects With Moderate to Severe Chronic Plaque Psoriasis
• Effects of Subcutaneous Hyaluronidase Administration on Psoriatic Plaques
• A Study to Evaluate the Irritation Potential of GSK2894512 Cream on Skin in Healthy Subjects
• The Immunological Basis for Treatment Resistance to Anti-TNF Treatments
• A Comparison of DFD01 Spray Versus Vehicle Spray in Subjects With Moderate Psoriasis
• Efficacy Study of Trichuris Suis Ova to Treat Chronic Plaque Psoriasis
• A Comparison of DFD01 Spray Versus Comp01 Lotion, Vehicle Spray and Vehicle Lotion in Subjects With Moderate Psoriasis
• A Vasoconstriction Study With LEO 90100
• Study Comparing AM001 Cream to Vehicle in the Treatment of Plaque Psoriasis
• Brodalumab Drug-Drug Interaction (DDI) and Intensive Pharmacodynamic (PK) Study in Psoriasis Subjects
• A Study to Evaluate the Efficacy and Safety/Tolerability of Subcutaneous MK-3222 in Participants With Moderate-to-Severe Chronic Plaque Psoriasis (MK-3222-012)
• Topical Double-blind, Randomized, Placebo-controlled Study in Psoriasis Patients
• Combined Cumulative Irritation Potential and Repeat Insult Patch Test of LEO 90100
• Photocil (Topical) for the Treatment of Psoriasis Vulgaris
• Parallel Group Trial to Evaluate the Efficacy and Safety of Loion® Compared to 10% Salicylic Acid in Patients With Chronic Psoriasis Capitis
• Long Term Study to Evaluate Safety and Efficacy of M518101 in Subjects With Plaque Psoriasis
• A Study of Topical Indigo Naturalis Treatment in Patients With Mild to Moderate Plaque-type Psoriasis
• A Study to Evaluate the Pharmacokinetics (PK), Safety and Tolerability, Immunogenicity, and Pharmacodynamics (PD) of GSK2800528 in Healthy Subjects.
• A 12-week Dose-Ranging Trial in Patients With Moderate to Severe Plaque Psoriasis
• Autologous Cytokine Induced Killer Cells (CIK) for Patients With Severe Psoriasis
• Subject Reported Target-lesion Numeric Rating Scale Evaluation by Subjects With Plaque Psoriasis Treated With Clobex® (Clobetasol Propionate) Spray 0.05%
• Study to Demonstrate Equivalent Efficacy and to Compare Safety of Biosimilar Etanercept (GP2015) and Enbrel
• Thalidomide in the Treatment of Chronic Plaque Psoriasis.
• A Comparison of 000-0551 Lotion Versus Vehicle Lotion in Subjects With Plaque Psoriasis (Study -305)
• Evaluate the Efficacy and Safety of M518101 in Subjects With Plaque Psoriasis
• Preference Between Two Autoinjectors in Patients With Rheumatoid Arthritis and Plaque Psoriasis Treated With Etanercept
• Study to Evaluate the Efficacy and Safety of M518101 in Subjects With Plaque Psoriasis
• Skin Transcriptional Profiles In Psoriatic Patients Under Adalimumab Biotherapy
• A Comparison of 000-0551 Lotion Versus Vehicle Lotion in Subjects With Plaque Psoriasis (Study -304)
• Vascular Inflammation in Psoriasis - Extension Study
• LEO 90100 Compared to Vehicle in Subjects With Psoriasis Vulgaris
• A Study of the Efficacy, Safety and Tolerability of CNTO 1959, a Human Anti-IL 23 Monoclonal Antibody in Participants With Palmoplantar Pustulosis
• Study to Evaluate the Pharmacokinetics and the Safety of M518101 in Plaque Psoriasis Patients
• An Exploratory Psoriasis Plaque Test Study With Different Dose Combinations of Calcipotriol Plus Betamethasone Dipropionate in the Daivobet® Gel Vehicle in Psoriasis Vulgaris
• A Study to Evaluate the Efficacy and Safety of VB-201 in Patients With Psoriasis
• Safety and Effectiveness of CNDO 201Trichuris Suis Ova (TSO) for the Treatment of Moderate to Severe Plaque Psoriasis
• Tofacitinib Ointment For Chronic Plaque Psoriasis
• Paired Psoriasis Lesion, Comparative, Study to Evaluate MOL4239 in Psoriasis
• Efficacy Study on Dimethyl Fumarate to Treat Moderate to Severe Plaque Psoriasis
• A Study Evaluating The Efficacy And Safety Of CP-690,550 In Asian Subjects With Moderate To Severe Plaque Psoriasis
• Economic Evaluation of Systemic Treatments for Moderate-to-severe Psoriasis
• Using an Internet Study to Improve Adherence for Psoriasis Patients
• Anakinra for Inflammatory Pustular Skin Diseases
• An Open-label, Non-controlled Study of KHK4827 in Subjects With Psoriasis
• A Phase 3 Clinical Study of KHK4827
• A Dose Ranging Study to Evaluate the Safety and Efficacy of GSK2586184 in Patients With Chronic Plaque Psoriasis
• Evaluation of Ixekizumab Using Auto-Injector or Prefilled Syringe in Participants With Moderate to Severe Plaque Psoriasis
• The Pharmacokinetics of LEO 90105 (Calcipotriol Hydrate Plus Betamethasone Dipropionate) in Japanese Subjects With Extensive Psoriasis Vulgaris
• PK and PD Study of Calcitriol 3 mcg/g Ointment in Pediatric Subjects With Plaque Psoriasis
• Nicotinamide in the Treatment of Psoriasis
• A Study to Determine the Efficacy of Taclonex Topical Suspension as a Supplement to Non-biologic Systemic Therapy
• A Phase 2 Clinical Study of KHK4827
• Olux E Foam and Sorilux Foam Combination Therapy for the Maintenance of Treatment Response in Patients With Moderate Plaque Psoriasis
• Antipsoriatic Effect of a Topical Formulation for the Treatment of Psoriasis Vulgaris
• Multiple Dose Escalation Study In Medically Stable Subjects With Psoriasis
• Dosage Determination Trial for Indigo Naturalis Extract in Oil Ointment
• A Study to Evaluate the Efficacy and Safety/Tolerability of Subcutaneous Tildrakizumab (SCH 900222/MK-3222) in Participants With Moderate-to-Severe Chronic Plaque Psoriasis Followed by a Long-term Extension Study (MK-3222-011)
• LAS41008 in Moderate to Severe Chronic Plaque Psoriasis
• Cromoglicate in Psoriasis
• A Study to Evaluate the Efficacy and Safety of Subcutaneous MK-3222, Followed by an Optional Long-Term Safety Extension Study, in Participants With Moderate-to-Severe Chronic Plaque Psoriasis (MK-3222-010)
• Study of the Efficacy of Cloderm® Cream in the Treatment of Moderate Plaque Psoriasis
• Study Of The Mechanism Of Action Of CP-690,550 In The Skin Of Subjects With Moderate To Severe Chronic Plaque Psoriasis
• Efficacy and Safety of Brodalumab Compared With Placebo and Ustekinumab in Moderate to Severe Plaque Psoriasis Subjects
• P3 Study Brodalumab in Treatment of Moderate to Severe Plaque Psoriasis
• Efficacy, Safety, and Withdrawal and Retreatment With Brodalumab in Moderate to Severe Plaque Psoriasis Subjects
• Non-interventional Study of Long-term Treatment of Psoriasis With Calcipotriol Plus Betamethasone in Gel Formulation
• Patient Preference of Taclonex Ointment to Taclonex Scalp Suspension in Adult Subjects With Psoriasis Vulgaris
• Swiss Dermatology Network of Targeted Therapies (SDNTT)
• Addition of Modulators of Homocysteine to Adalimumab Therapy in the Treatment of Moderate to Severe Plaque Psoriasis
• A Study to Assess the Relative Bioavailability of New Oral Formulations of SRT2104 in Healthy Male Volunteers
• Evaluation of DD-25 Topical Cream for the Treatment of Psoriasis Vulgaris : Proof of Concept Study
• A Study to Determine the Efficacy and Safety of 122-0551 in Subjects With Plaque Psoriasis
• Pharmacokinetics of 122-0551 and Its Effects on Adrenal Suppression
• A Study of Ixekizumab in Participants With Active Psoriatic Arthritis
• Phase 3b Safety and Efficacy Study of Apremilast to Treat Moderate to Severe Plaque-plaque Psoriasis
• Effect of GLP-1 Analogs on Psoriasis in Type 2 Diabetic Patients
• A Clinical Study of Increased Dose of TA-650 in Patients With Psoriasis
• A Study to Evaluate Ustekinumab in Patients With Plaque Psoriasis in Asia-Pacific Countries
• A Phase 2 Dose Ranging, Evaluator-Blinded Study to Evaluate the Safety of Topical IDP-118
• TNF-alfa Inhibitors and Antibody Production in Patients With Psoriasis
• SHP-141C in Plaque Type Psoriasis
• A Study in Participants With Moderate to Severe Psoriasis (UNCOVER-3)
• 4 Year Extension Study of Efficacy and Safety of Secukinumab in Patients With Moderate to Severe Chronic Plaque-type Psoriasis
• Judging the Efficacy of Secukinumab in Patients With Psoriasis Using AutoiNjector: a Clinical Trial Evaluating Treatment Results (JUNCTURE)
• A Study of Escalating Doses of Itacitinib Administered Orally in Patients With Plaque Psoriasis
• A Study in Japanese Participants With Moderate-to-Severe Psoriasis
• Prospective Evaluation of the Radiographic Efficacy of Enbrel
• Trial of IMO-3100 in Patients With Moderate to Severe Plaque Psoriasis
• A Study to Determine the Efficacy and Safety of Halobetasol Propionate Lotion 0.05% in Subjects With Plaque Psoriasis
• A Short-contact Plaque Test Study With Daivobet® Gel in Psoriasis Vulgaris
• Effect of LEO 90100 on the HPA Axis and Calcium Metabolism in Subjects With Extensive Psoriasis VulgarisExtensive Psoriasis Vulgaris
• A Phase 3 Study in Participants With Moderate to Severe Psoriasis (UNCOVER-2)
• Intra-dermal Injections of DLX105 Into Lesional Skin in Patients With Mild-to-moderate Psoriasis Vulgaris
• A Multiple Dose Escalation Study of ASKP1240 in Subjects With Moderate to Severe Plaque Psoriasis
• Evaluate Safety and Tolerability of Calcipotriene Foam 0.005% in Pediatric Subjects With Mild/Moderate Plaque Psoriasis
• A Plaque Test Study With LEO 35299 in Psoriasis Vulgaris
• Single Rising Dose Study of BI 655066 in Patients With Moderate and Severe Psoriasis
• A Physiological Study on Downregulation of EGF-receptors in the Skin by Topical Exposition With EGF
• Safety, Tolerability, PD & PK of Calcipotriene 0.005% Foam, Under Maximal Use in 12-16 Year Olds With Plaque Psoriasis
• A Study to Evaluate the Effectiveness of STELARA ™ (USTEKINUMAB) in the Treatment of Scalp Psoriasis
• Adalimumab-psoriasis and Small Bowel Lesions
• First Study of Secukinumab in Pre-filled Syringes in Subjects With Chronic Plaque-type Psoriasis: Response at 12 Weeks
• Vascular Inflammation in Psoriasis Trial (The VIP Trial)
• A Study of Ustekinumab to Evaluate a "Subject-tailored" Maintenance Dosing Approach in Subjects With Moderate-to-Severe Plaque Psoriasis
• Extension Study of Secukinumab Prefilled Syringes in Subjects With Moderate to Severe Chronic Plaque-type Psoriasis Completing Preceding Psoriasis Phase III Studies With Secukinumab
• Etanercept Treatment in Patients With Moderate to Severe Plaque Psoriasis Who Lost Response to Adalimumab
• Pharmacokinetics and Pharmacodynamics of BCT194 in Psoriatic Patients
• Distribution of Secukinumab (AIN457) Into Dermal Interstitial Fluid After a Single Subcutaneous Administration of 300 mg
• Multiple-dose Regimen Study to Assess Effect of 12 Months of Secukinumab Treatment on Skin Response and Biomarkers in Psoriasis Patients
• LEO 90100 in the Treatment of Psoriasis Vulgaris
• LEO 90100 Compared With Calcipotriol Plus Betamethasone Dipropionate Ointment, LEO 90100 Vehicle and Ointment Vehicle in Subjects With Psoriasis Vulgaris
• Influence of Atorvastatin on Psoriasis Severity and Endothelial Function
• A Long Term Study To Evaluate The Safety, Tolerability And Efficacy Of CP-690,550 In Patients With Moderate To Severe Plaque Psoriasis And/Or Psoriatic Arthritis
• The Quality of Life Study in Psoriasis Patients After Ustekinumab Treatment
• Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Clinical Effects of AMG 811 in Subjects With Psoriasis
• Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Clinical Effects of AMG 557 in Adults With Psoriasis
• A Phase 2b Study of Baricitinib in Participants With Moderate to Severe Psoriasis
• A Clinical Pharmacology of KHK4827 in Healthy Volunteers and Subject With Moderate to Severe Psoriasis
• A Study of the Safety, Tolerability, Pharmacokinetics (What the Body Does to the Drug), and Pharmacodynamics (What the Drug Does to the Body) of CNTO 1959 Following a Single Subcutaneous (Under the Skin) Administration in Japanese Participants With
• Study to Evaluate Apo805K1 in Subjects With Moderate to Severe Chronic Plaque Psoriasis
• A Study to Evaluate CNTO 1959 in the Treatment of Patients With Moderate to Severe Plaque-type Psoriasis
• A Phase 3 Study in Participants With Moderate to Severe Psoriasis
• An Exploratory Psoriasis Plaque Test Study With LEO 29102 Plus Calcipotriol, Ointment, in Psoriasis Vulgaris
• Evaluation of the Efficacy, Safety and Toleration of CT327 Ointment in Patients With Psoriasis Vulgaris
• Efficacy and Tolerability of LAS41004 Formulations in a Non-occlusive Psoriasis Plaque Test
• The Effect of Glucagon Like Peptide (GLP)-1 in Psoriasis
• GLP-1 Receptors in Normal Skin and Skin From Patients With Psoriasis
• Comparison of Indigo Naturalis Oil Extract and Calcipotriol Solution in Treating Psoriasis
• Study Evaluating the Efficacy and Safety of Triptergium Wilfordii and Acitretin in Psoriasis Vulgaris - CHINA201002016-2
• Post Marketing Surveillance To Observe Safety And Efficacy Of Enbrel In Pediatric Patients With Psoriasis
• Steroids Added to Dithranol and Narrow Band UVB(Ultraviolet B) (UVBnb) in Psoriasis
• LEO 90105 Ointment in Japanese Subjects With Psoriasis
• Efficacy and Safety of Intravenous and Subcutaneous Secukinumab in Moderate to Severe Chronic Plaque-type Psoriasis
• Efficacy and Safety of Subcutaneous Secukinumab (AIN457) for Moderate to Severe Chronic Plaque-type Psoriasis Assessing Different Doses and Dose Regimens
• Assessment for Tachyphylaxis to Topical Corticosteroids in the Treatment of Psoriasis
• Safety, Pharmacokinetics, and Efficacy of RA-18C3 in Subjects With Moderate to Severe Psoriasis
• A Phase IV Clinical Trial to Study the Safety, Tolerability and Efficacy of Tinefcon in Patients With Plaque Psoriasis
• Study to Test the Effectiveness of a New Treatment for Scalp Psoriasis
• Efficacy and Safety of Subcutaneous Secukinumab for Moderate to Severe Chronic Plaque-type Psoriasis for up to 1 Year
• Exploratory Study to Investigate Efficacy of LAS41004 in a Psoriasis Plaque Test
• Safety and Efficacy of Secukinumab Compared to Etanercept in Subjects With Moderate to Severe, Chronic Plaque-Type Psoriasis
• Cardiovascular Risk Assessment in Patients With Severe Psoriasis Treated With Biologic Agents
• Effective Study of Live Attenuated Varicella Vaccine to Treat Severe Resistant Psoriasis
• A Psoriasis Plaque Test Study With LEO 90100 Cutaneous Spray, Ointment, in Psoriasis Vulgaris
• Efficacy of Vitamin D3 for the Treatment of Psoriatic Patients With Vitamin D Deficiency and Insufficiency
• Fumaric Acid Versus Fumaric Acid Plus Narrow Band Type B Ultraviolet (UVB) for Psoriasis
• Efficacy, Tolerability and Handling of Daivobet® Gel in Patients With Psoriasis Vulgaris
• Cardiovascular Effects in Psoriasis Patients Treated With Adalimumab.
• Cell Responses to IFN-gamma
• Efficacy and Safety of Etanercept 50 mg Once Weekly Plus As Needed Topical Agent in Moderate to Severe Plaque Psoriasis
• A One-Year Study To Evaluate The Efficacy And Safety Of CP-690,550 For Patients With Moderate To Severe Chronic Plaque Psoriasis
• Study to Investigate the Efficacy and the Safety of M518101 in Plaque Psoriasis Patients
• AN2728 Topical Ointment to Treat Mild-to-Moderate Plaque-Type Psoriasis
• A Psoriasis Plaque Test on LEO 27989 Ointment and Calcipotriol Plus LEO 27989 Ointment in Patients With Psoriasis Vulgaris
• Clinical Trial to Investigate Efficacy of LAS41004 in Psoriasis
• Open Clinical Study, Comparing Non-inferiority of Chronic Plaque Psoriasis
• A Study to Assess the Effect of Ustekinumab (Stelara®) and Etanercept (Enbrel®) in Participants With Moderate to Severe Psoriasis (MK-0000-206)
• A One-Year Study To Evaluate The Effects And Safety Of CP-690,550 In Patients With Moderate To Severe Chronic Plaque Psoriasis
• A 12-Day Randomized, Blinded, Vehicle and Active Comparator-Controlled Study to Determine the Efficacy and Safety of Six Concentrations of Topical E6201 Gel in Subjects With Psoriasis Vulgaris
• Trial of CF101 to Treat Patients With Psoriasis
• First Human Dose Study of Anti-IL-20 in Psoriasis: A Study of Safety, Tolerability and Early Signals of Biologic and Clinical Effects
• Open Label, Single Dose, Non-randomized Study to Assess the Drug to Drug Interaction of Briakinumab on CYP Substrates.
• Safety Study of Ointment for the Treatment of Plaque-type Psoriasis
• A Double Blind Study in Pediatric Subjects With Chronic Plaque Psoriasis, Studying Adalimumab vs. Methotrexate
• Randomized Study of PH-10 for Psoriasis
• CP-690-550 Ointment For Chronic Plaque Psoriasis
• Efficacy of Alitretinoin Treatment in Patients With Pustular Form of Psoriasis
• A Phase 3, Multi Site, Randomized, Double Blind, Placebo Controlled Study Of The Efficacy And Safety Comparing CP- 690,550 And Etanercept In Subjects With Moderate To Severe Chronic Plaque Psoriasis
• Evaluation of Lymphocytic Infiltrate, Dendritic Cells and Cytokines Expression in Psoriatic Lesion and Normal Skin Before and After TNF Alfa Inhibitors Therapy
• A Study to Evaluate and Compare the Efficacy and Pharmacokinetics of MK-0873 for the Treatment of Plaque Psoriasis (MK-0873-022)
• Evaluate Efficacy, and Safety of Topical Therapy and Etanercept in Subjects With Moderate to Severe Plaque Psoriasis
• Regulatory T-cells in Psoriasis Patients as Targets for Therapy
• Study to Evaluate Safety and Effectiveness of Oral Apremilast (CC-10004) in Patients With Moderate to Severe Plaque Psoriasis.
• Pivotal Efficacy and Safety Registration Trial of FP187 in Moderate to Severe Plaque Psoriasis
• Effect of LEO 80185 Gel on the HPA Axis and Calcium Metabolism in Subjects With Extensive Psoriasis Vulgaris
• Efficacy Study of the Combination Mometasone + Salicylic Acid in Patients With Psoriasis
• Effectiveness of Association Mometasone Furoate 0.1% and Salicylic Acid 5% Compared With Mometasone Furoate
• Low-Dose (17.5 mg/Day) Acitretin: Comparable Efficacy Without the Side Effects?
• A Study to Determine the Optimal Dose of Tildrakizumab (SCH 900222/MK-3222) for the Treatment of Moderate-to-severe Chronic Plaque Psoriasis (P05495) (MK-3222-003)
• ACT-128800 in Patients With Moderate to Severe Chronic Plaque Psoriasis
• Effects of Desoximetasone Spray 0.25% in Patients With Moderate to Severe Plaque Psoriasis
• Effects of Desoximetasone Spray 0.25% on Moderate to Severe Plaque Psoriasis
• Study to Evaluate Vectical in Combination With Clobex Spray to Treatment Plaque Psoriasis
• Apremilast for Chronic Plaque Psoriasis (CPP) Patients Who Have Failed One Course of Biologic Therapy
• Efficacy and Safety of Xamiol® Gel Compared to Calcipotriol Scalp Solution in Patients With Scalp Psoriasis
• Study to Evaluate Safety and Effectiveness of Oral Apremilast (CC-10004) in Patients With Moderate to Severe Plaque Psoriasis
• LEO 80185 in the Treatment of Psoriasis Vulgaris on the Non-scalp Regions of the Body (Trunk and/or Limbs)
• Dose Ranging Study to Compare the Efficacy and Safety of Methotrexate in Plaque Type Psoriasis
• A Study To Evaluate The Effects And Safety Of Treatment, Treatment Withdrawal, Followed By Re-Treatment With CP-690,550 In Subjects With Moderate To Severe Chronic Plaque Psoriasis
• Efficacy and Safety of Adalimumab in Patients With Psoriasis and Obstructive Sleep Apnea
• A Study to Evaluate Safety and Efficacy of Infliximab in Chinese Participants With Moderate to Severe Plaque-type Psoriasis
• Psoriasis Inflammation and Systemic Co Morbidities
• Blinded Study of Topical Investigational Lotion Vs. Approved Cream in Treatment of Plaque Psoriasis
• A Long Term Study To Evaluate The Safety And Tolerability Of CP-690,550 For Patients With Moderate To Severe Chronic Plaque Psoriasis
• Study of the Clinical Activity, Safety, and Tolerability of SRT2104 in Subjects With Moderate to Severe Plaque-Type Psoriasis
• Safety, Tolerability and Pharmacokinetics of MK-0873 Following Patch Application in Healthy Participants and Psoriasis Participants (MK-0873-020)
• The Purpose of This Study is to Demonstrate the Safety and Effectiveness of Calcipotriene Foam in Subjects With Scalp and Body Psoriasis
• Study to Evaluate Effect of Pandel Cream 0.1% on HPA Axis in Pediatric and Adult Population
• Pioglitazone in Psoriasis- A Clinical and Molecular Study.
• AIN457 Regimen Finding Extension Study in Participants With Moderate to Severe Psoriasis
• The Effect of Algae Dunaliella Bardawil on Psoriasis (2)
• Safety and Efficacy of LEO 80185 Gel in Adolescent Subjects (Aged 12 to 17) With Scalp Psoriasis
• Study to Investigate Dose-related Efficacy of LAS41004 in the Treatment of Psoriasis
• A Proof of Concept Study Comparing Three Doses of an Oral Solution of LEO 22811 With a Placebo Oral Solution for the Treatment of Psoriasis Vulgaris
• Ammonium Lactate Lotion 12% (Lac-hydrin®) and Halobetasol Propionate Ointment 0.05% (Ultravate®) in the Treatment and Maintenance of Psoriasis
• A Study in Participants With Moderate to Severe Psoriasis
• A Psoriasis Plaque Test Comparing Eight Different Formulations of Vitamin D Analogues for the Treatment of Psoriasis
• Study to Assess the Long-term Safety, Tolerability, and Efficacy of AMG 827 in Subjects With Psoriasis
• Study Evaluating the Safety and Effectiveness of Etanercept for the Treatment of Pediatric Psoriasis
• A Safety/Efficacy Study of a Non-steroid, Topical Cream Treatment of Psoriasis Over 12-weeks
• A Study to Explore Efficacy and Safety of ASP015K in Subjects With Moderate to Severe Psoriasis
• Acitretin or Tazarotene Gel and Excimer Laser for Treatment of Psoriasis
• Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 139 in Healthy Subjects and Subjects With Moderate to Severe Psoriasis
• Safety and Efficacy of Ustekinumab in Patients With Palmo-Plantar Pustular Psoriasis or With Palmo-Plantar Pustulosis
• A Study of the Safety and Efficacy of Ustekinumab in Adolescent Patients With Psoriasis (CADMUS)
• Efficacy and Safety of Ustekinumab in Patients With Moderate to Severe Palmar Plantar Psoriasis
• The Influence of Adalimumab on Cardiovascular and Metabolic Risk in Psoriasis
• Safety and Efficacy of LEO 80185 Topical Suspension in Adolescent Subjects (Aged 12 to 17) With Scalp Psoriasis
• Ustekinumab Safety and Surveillance Program Using the Ingenix NHI Database
• Study of Therapeutic Options for Subjects Discontinuing Efalizumab and Experiencing Disease Recurrence
• Safety and Efficacy of Multiple Doses of BT061 in Patients With Moderate to Severe Chronic Plaque Psoriasis
• A Dose Ranging Study of AIN457 in Patients With Moderate to Severe Chronic Plaque-type Psoriasis
• A Safety and Efficacy Study of Ustekinumab in Patients With Plaque Psoriasis Who Have Had an Inadequate Response to Methotrexate
• Can We Miss Pigmented Lesions in Psoriasis Patients?
• Topical Treatment of Scalp Psoriasis With the Fixed Combination of Calcipotriol and Betamethason (Xamiol® Gel)
• STA-21 Topical Efficacy on Psoriasis
• A Double-blind, Placebo-controlled, Randomized, Parallel-group Study to Evaluate the Activity of Oral AB1010 in Adults Patients With Moderate to Severe Chronic Plaque Psoriasis
• Desoximetasone Spray 0.25%, Hypothalamic Pituitary Adrenal (HPA) Axis Study
• A Psoriasis Plaque Test Comparing Products for the Treatment of Psoriasis Vulgaris
• Dose Ranging Study to Assess the Efficacy and Safety of Acitretin in Severe Plaque Type Psoriasis
• Safety and Efficacy Study of a Novel Ointment to Treat Plaque Type Psoriasis
• Comparison of Refined and Crude Indigo Naturalis Ointment in Treating Psoriasis
• A Study for Adults With Plaque Psoriasis
• Desoximetasone Spray 0.05%, 0.25%; Dose Ranging Study
• Safety and Efficacy Study of Combination Treatment With Excimer Laser, Clobex Spray, and Vectical Ointment in the Treatment of Psoriasis
• Efficacy and Tolerability of Prednisolone Acetate 0.5% Cream Versus Betamethasone Valerate 0.1% Cream in Cortisosensitive Dermatosis
• Study Evaluating Single Dose Of ILV-095 In Psoriasis Subjects
• A Study of the Safety and Effectiveness of Ustekinumab (Stelara) in Chinese Patients With Psoriasis
• A Study Comparing LEO 80190 Ointment With Hydrocortisone Ointment, Both Applied Once Daily in the Treatment of Psoriasis Vulgaris on the Face and Intertriginous Areas
• Erlotinib for Treatment of Psoriasis
• Study to Assess VB-201 in Patients With Psoriasis
• The Efficacy and Safety of Adding Methotrexate to Etanercept in Psoriasis
• Determination of the Efficacy and Safety of Psirelax in the Relief of the Disease in Psoriasis
• Evaluation of the Efficacy and Safety of Indigo Naturalis Oil Extract on Psoriatic Nails
• CT 327 in the Treatment of Psoriasis Vulgaris
• Study Comparing 2 Different Strategies For Management of Subjects With Plaque Psoriasis Who Have Responded to Etanercept
• Comparing the Efficacy of Ultravate Ointment in Combination With Lac-Hydrin Lotion in the Treatment of Psoriasis
• Evaluate Safety/Efficacy of Two Treatment Regimens for Vectical™ Ointment & Clobex® Spray for Moderate Plaque Psoriasis
• Safety and Efficacy of BFH772 in Psoriasis Patients
• Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 827 in Subjects With Psoriasis
• Safety and Efficacy of Etanercept in Patients With Psoriasis Who Failed to Respond to Other Biologic Treatments
• Alefacept in Subjects With Chronic Plaque Psoriasis Who Failed to Respond to Anti-TNF Therapy
• An Efficacy and Safety Study of PH-10 Aqueous Hydrogel for the Treatment of Plaque Psoriasis
• AIN457 Regimen Finding Study in Patients With Moderate to Severe Psoriasis
• Aminopterin Pharmacokinetic Study In Moderate to Severe Psoriasis
• Study Evaluating the Efficacy and Safety of Etanercept and Acitretin in Korean Patient With Moderate to Severe Psoriasis
• Mechanism of Action Study for Psoriasis
• Fluphenazine Hydrochloride for Psoriasis
• Safety and Efficacy of Adalimumab in Patients Who Showed an Unsatisfactory Response to Etanercept
• A Study of the Safety and How the Body Affects a Drug (CNTO 1959) in Healthy Volunteers and in Patients With Psoriasis
• Taclonex Ointment With Hydrogel Patch Occlusion for the Treatment of Psoriasis
• A Dose Finding Study of AEB071 Assessing Psoriasis Area and Severity Index in Patients With Plaque Psoriasis
• Study to Investigate the Efficacy and the Safety of M518101 in Psoriasis Patients
• Clobetasol Propionate Spray Versus Vehicle Spray for the Management of Moderate to Severe Plaque Psoriasis of the Scalp
• A Psoriasis Plaque Test With LEO 29102 Cream and Its Combination Products
• BTT1023 in Psoriasis
• Single-Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 827
• A Study to Evaluate the Efficacy and Tolerability of Topical Therapies for the Condition of Plaque-Type Psoriasis
• ACT-128800 in Psoriasis
• Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Doses of AbGn-168 in Psoriasis
• A Plaque Test Comparing the Anti-psoriatic Effect of Marketed Products for Topical Use for Psoriasis Vulgaris
• Evaluation of the Efficacy and Tolerability of Clobetasol Propionate Foam Compared to Vehicle Foam
• LEO 22811 - A Phase 1, Double-Blind, Placebo-controlled, Single and Multiple Oral Dose Study in Healthy Subjects
• The Safety & Efficacy of Etanercept in Psoriasis Patients Who Have Not Responded to Adalimumab
• Dose Optimization of Infliximab in Moderate to Severe Plaque Psoriasis (Study P05315)
• Trial of an Injectable Biologic and U0279 as Combination Therapy for Severe Plaque-Type Psoriasis
• Combined Inhibition of Dipeptidyl Peptidase IV (DPIV/CD26) and Aminopeptidase N (APN/CD13) in the Treatment of Psoriasis
• Safety and Efficacy Study of Bimosiamose Cream to Treat Psoriasis
• A Study of Ruxolitinib Phosphate Cream When Applied to Patients With Plaque Psoriasis
• Safety and Efficacy of TACLONEX Ointment in Adolescent Patients (Aged 12 to 17 Years) With Psoriasis Vulgaris
• Multiple-loading Dose Regimen Study in Patients With Chronic Plaque-type Psoriasis
• Open Label Study Etanercept's Maintenance Dose in Obese Patients With Moderate to Severe Plaque Type Psoriasis
• A Single-Center Exploratory Study to Assess the Activity of CRx-197-002 in Plaque Psoriasis
• Assess the Long-term Effectiveness and Safety of Amevive (Alefacept) in Subjects With Moderate to Severe Chronic Plaque Psoriasis
• Safety and Tolerability of Repeat Courses of IM Alefacept
• Analysis of Response of Subjects With Atopic Dermatitis or Psoriasis to Oral Vitamin D3
• Topical Application of AS101 for the Treatment of Psoriasis
• Efficacy and Safety of Topical ALT-2074 (SYI-2074) for Treatment of Chronic Plaque Psoriasis
• A Dose Ranging Study of the Effect of Ruxolitinib Phosphate Cream When Applied to Patients With Plaque Psoriasis
• Efficacy and Safety Study of Apremilast (CC-10004) in Subjects With Moderate-to-Severe Plaque-Type Psoriasis (Core Study)
• Combining Topical Corticosteroid and LCD Treatment for Localized Plaque Psoriasis
• Efficacy and Safety of LEO 19123 Cream in the Treatment of Psoriasis Vulgaris
• Efficacy and Safety Study of CD 2027 Spray in Subjects With Plaque-type Psoriasis
• Elocon vs Fluticasone in Localized Psoriasis (P03197)
• Pharmacokinetic (PK) and Pharmacodynamic (PD) Study of CD 2027 Spray in Adults With Plaque-type Psoriasis
• A Phase I Study to Assess Novel Cream in a Psoriasis Plaque Test
• A Phase I Study to Assess Novel Ointment in a Psoriasis Plaque Test
• An Observational Study of Infliximab Injection in Ankylosing Spondylitis, Rheumatoid Arthritis, Psoriatic Arthritis and Psoriasis Participants
• Safety and Efficacy Study of A Novel Ointment to Treat Plaque Type Psoriasis
• Safety and Efficacy Study of A Novel Ointment to Treat Plaque Type Psoriasis
• A Phase 3 Trial to Look at the Safety and Effectiveness of Ustekinumab in Korean and Taiwanese Subjects With Moderate to Severe Plaque-type Psoriasis
• To Demonstrate the Superior Efficacy of NYC 0462 Ointment Over That of the Placebo in the Treatment of Plaque Psoriasis
• A Proof of Concept Study With 0.5% Roflumilast Cream in Patients With Mild to Moderate Plaque Psoriasis
• TRUST Study: Raptiva ® in Hand & Foot Psoriasis
• Efficacy/Safety/Subject Satisfaction/Duration of Response of Clobetasol Propionate Spray vs Ointment in Plaque Psoriasis
• An Open-Label, Multi-Center Trial in the Treatment of Subjects With Moderate to Severe Plaque Type Psoriasis
• An Efficacy and Safety Study of Ustekinumab (CNTO 1275) in Participants With Plaque Psoriasis
• Evaluation of the Efficacy of Acitretin Therapy for Nail Psoriasis
• Dose Ranging Study of the Safety and Efficacy of R115966 in Plaque Psoriasis
• Effectiveness and Safety of Topical Halobetasol Propionate in the Treatment of Patients With Psoriasis
• Study Comparing the Efficacy and Safety of ABT-874 to Etanercept and Placebo in Subjects With Moderate to Severe Chronic Plaque Psoriasis
• Observational Study Evaluating Etanercept (Enbrel®) In Subjects With Plaque-Type Psoriasis In Usual Care Settings
• Combining Acitretin and Efalizumab in the Therapy of Chronic Plaque Psoriasis
• LCD Solution Versus Calcipotriol Cream in the Treatment of Moderate Plaque Psoriasis
• Effect of Calcipotriol Plus Hydrocortisone Ointment on the Adrenal Hormone Balance and Calcium Metabolism in Patients With Psoriasis Vulgaris on the Face and Skin Folds
• ChangE From Any Systemic psoriasiS therapY to Raptiva
• Effects of Capsaicin on the Structure, Distribution, and Function of Cutaneous Small Nerve Fibers in Psoriatic Skin
• Open-label Study to Evaluate Safety of Multiple Courses of IM Alefacept During Treatment of Chronic Plaque Psoriasis
• Study Comparing the Efficacy and Safety of ABT-874 to Etanercept and Placebo in Subjects With Moderate to Severe Chronic Plaque Psoriasis
• Efficacy and Safety of Calcipotriol Plus Hydrocortisone Ointment in Psoriasis Vulgaris on the Face and Skin Folds
• Study to Compare U0267 Against Vehicle in Subjects With Plaque-type Psoriasis Two of Two Phase 3 Studies
• Study to Compare U0267 Against Vehicle in Subjects With Plaque-type Psoriasis One of Two Phase 3 Studies
• A Study to Assess the Clinical Effects of Navarixin in Participants With Psoriasis (MK-7123-009)
• A Study of Safety and Efficacy Comparing ABT-874 Versus Methotrexate in Subjects With Moderate to Severe Plaque Psoriasis
• Investigation of Antipsoriatic Effects of UVB-induced Synthesis of 1alpha, 25-Dihydroxyvitamin D3 (1alpha, 25(OH)2D3, Calcitriol)in Keratinocytes of Psoriatic Skin, Using Cytochrom-P(CYP)Inhibitor Ketokonazol
• Topical CP-690,550 For Chronic Plaque Psoriasis
• Open Label Study of Alefacept Injections to Patients With Moderate to Severe Psoriasis
• Effectiveness and Safety of 3 Dosing Regimens of CP-690,550 to Placebo in Subjects With Moderate to Severe Chronic Plaque Psoriasis
• A Study to Assess the Efficacy and Safety of Two Dosing Regimens of Alefacept in Subjects Weighing Between 100kg and 150kg With Moderate to Severe Chronic Plaque Psoriasis
• A Study to Assess the Efficacy and Safety of Alefacept in Psoriasis Patients for Whom Conventional Treatment is Ineffective or Inappropriate
• Efficacy and Safety of Calcipotriol Plus Betamethasone Dipropionate Gel Compared With Tacalcitol Ointment and the Gel Vehicle Alone in Patients With Psoriasis Vulgaris
• A Study Comparing AIN457 to Placebo in Subjects With a Diagnosis of Moderate to Severe Stable Plaque Psoriasis
• A Study to Evaluate the Safety and Efficacy of Efalizumab in Adult Patients With Moderate to Severe Plaque Psoriasis With Involvement of the Scalp
• Chondroitin Sulphate Efficay/Safety in Patients With Knee Osteoarthritis and Psoriasis
• Dose Response and Safety Study of Topical Methotrexate for the Treatment of Fingernail Psoriasis
• Study Evaluating Etanercept for the Treatment of Moderate to Severe Psoriasis
• Safety & Effectiveness of Clobex Spray, Followed by Calcitriol Ointment in Management of Plaque Psoriasis
• Assess the Efficacy and Safety of Alefacept With Narrow Band Ultraviolet B Phototherapy (nbUVB) vs. Alefacept Alone in Chronic Plaque Psoriasis Subjects
• Long-Term One Year Use of Alefacept (Amevive®) in Moderate to Severe Chronic Plaque Type Psoriasis
• Study of the Safety and Efficacy of Adalimumab in Subjects With Moderate to Severe Chronic Plaque Psoriasis
• Study of Two Dosing Schedules of Adalimumab in Subjects With Moderate to Severe Chronic Plaque Psoriasis
• Extension Study of Two Dosing Schedules of Adalimumab in Subjects With Moderate to Severe Chronic Plaque Psoriasis
• Multicenter Study of the Safety and Efficacy of Adalimumab in Subjects With Moderate to Severe Chronic Plaque Psoriasis
• Efficacy and Safety of Calcipotriol Plus Hydrocortisone Ointment Compared With Tacalcitol Ointment in Patients With Psoriasis on the Face and Skin Folds
• Safety and Efficacy of Combining nbUVB to Etanercept in Patients
• Safety and Efficacy of Infliximab in Palmoplantar Psoriasis
• Open Label Continuation Study in Moderate to Severe Psoriasis
• Study of Dose-Effect of COL-121 Ointment in Patients With Plaque-Type Psoriasis
• Open Label, Safety and Efficacy Study of Topical Investigational Drug to Treat Patients With Psoriasis
• Effect of Topical Calcipotriene/Betamethasone (Taclonex) in Managing Localized Breakthrough in Moderate to Severe Plaque Psoriasis in Patients Receiving Efalizumab (Raptiva)
• Double-Blind, Randomized, Placebo-controlled Comparison of CC-10004 in Subjects With Moderate to Severe Plaque Type Psoriasis
• Open-Label,Single-Arm Pilot Study to Evaluate the Pharmacodynamics, Pharmacokinetics, Safety, and Preliminary Efficacy of CC1004 in Subjects With Severe Plaque Type Psoriasis
• A Study to Evaluate the Safety and Effectiveness of Doxercalciferol Capsules in Participants With Moderate to Severe Psoriasis
• A Safety and Efficacy Study of a Topical Gel for the Treatment of Mild to Moderate Psoriasis
• Evaluation of Etanercept in Patients With Plaque Psoriasis After Stopping Ciclosporin Therapy
• Study Evaluating Safety of Etanercept in Treatment of Patients With Moderate to Severe Psoriasiswith Etanercept
• Effects of Etanercept on Nail Psoriasis and Plaque Psoriasis
• Efficacy and Tolerability Study of Topical Ciclosporin in a Psoriasis Plaque Test
• Adalimumab in Combination With Topical Treatment (Calcipotriol/Betamethasone) in Subjects With Moderate to Severe Psoriasis and Insufficient Response to Classic Systemic Treatment
• A Study Comparing the Safety and Efficacy of Two Dosing Regimens of ABT-874 to Placebo in Subjects With Moderate to Severe Chronic Plaque Psoriasis
• Study Evaluating The Safety And Tolerability Of ILV-094 In Subjects With Psoriasis
• Study of CRx-191 to Assess Activity in Plaque Psoriasis
• Topical PH-10 Aqueous Hydrogel and Photodynamic Therapy for Psoriasis
• A Phase II Study of MEDI-507, Administered by Injection to Adults With Psoriasis
• Paired-Comparison Study Evaluating the Efficacy and Safety of E6201 Versus Vehicle for the Treatment of Plaque-Type Psoriasis
• Apremilast Safety and PK Study in Recalcitrant Plaque Psoriasis
• Treatment of Mild to Moderate Joint Pain in Patients With Chronic Plaque Psoriasis Receiving Efalizumab
• Psoriasis Longitudinal Assessment and Registry (PSOLAR)
• A Study of R3421 in Patients With Moderate to Severe Chronic Plaque Psoriasis.
• Study to Evaluate the Immune Response to Pneumococcal Vaccine in Alefacept-treated Adults With Chronic Plaque Psoriasis
• Effects of TNF-alpha Antagonism (Etanercept) in Patients With the Metabolic Syndrome and Psoriasis
• Mechanistically-based Optimization of UV Radiation Therapy in Psoriasis
• Centocor Microarray Study of Patients
• Assessment and Tracking of Long-term Alefacept Safety
• An Efficacy and Safety Study of CNTO 1275 Compared to Etanercept in Patients With Plaque Psoriasis
• AMG 714 20060349 Multiple Dose Study in Moderate to Severe Psoriasis Subjects
• Efalizumab for Treatment of Patients With Moderate to Severe Psoriasis
• Subject Preference for Scalp Psoriasis Treatment
• Efficacy and Safety of Cyclosporine A Microemulsion in Maintenance Patients With Chronic Plaque Psoriasis
• A Study of Sequential Treatment With Daivobet (Betamethasone Dipropionate Plus Calcipotriol) and Daivonex (Calcipotriol) in Patients With Psoriasis.
• Efficacy, Safety, Preference and Response Duration of Clobex® Spray and Taclonex® Ointment in Psoriasis
• Efficacy, Tolerance and Satisfaction With CLOBEX® Spray When Used as Monotherapy or Add-on Therapy in Plaque Psoriasis
• A Comparison Between Clobetasol Propionate 0.05% (Clobex®) Spray and Clobetasol Propionate 0.05% (Olux®) Foam
• Safety and Efficacy Study of CF101 to Treat Psoriasis
• Bicillin L-A vs Placebo for the Treatment of Chronic, Plaque-Type Psoriasis Unresponsive to Topical Medications
• Evaluate the Efficacy and Safety of One Course of Amevive in Taiwan Patients
• A Study of Calcitriol BID Topical Treatment in Adolescents With Plaque Psoriasis
• Study of the Safety, Tolerability and Efficacy of BCT194 in Healthy Volunteers and Patients With Psoriasis.
• Randomized, Placebo and Ciclosporin Controlled Study of ISA247 in Plaque Psoriasis Patients
• Alefacept (Amevive) With or Without Narrowband UVB Treatment in Patients With Psoriasis.
• Maintenance Effect of Clobex Shampoo on Subjects With Moderate to Severe Scalp Psoriasis
• A Study of BMS-582949 in Patients With Moderate to Severe Plaque Psoriasis
• Study to Investigate the Safety, Tolerability, Absorption, Distribution, Metabolism, and Elimination of RWJ-445380 Administered to Patients With Plaque Psoriasis
• Efficacy and Safety of Acitretin Plus Pioglitazone in Patients With Psoriasis
• Safety and Efficacy of Topically Applied CTA018 in Plaque Psoriasis
• A Study to Evaluate the Effects of Efalizumab on Immune Responses in Subjects With Moderate Plaque Psoriasis
• The Effectiveness of Lower Cyclosporine Doses for Psoriasis
• Safety and Efficacy Study of Two Dose Regimens of Becocalcidiol in the Treatment of Plaque-Type Psoriasis
• Evaluate Whether Combination Therapy With Methotrexate and Raptiva in Psoriasis Patients is Safe and Increases Efficacy
• Chronic Plaque Psoriasis Study With Topical Formulation Of GW786034
• Fluphenazine Decanoate for Psoriasis
• A Placebo-Controlled Double-Blind Study on the Safety and Efficacy of Etanercept in Palmoplantar Pustulosis
• Topical Vitamin B12 in Chronic Plaque Psoriasis
• Adalimumab in Adult Japanese Subjects With Moderate to Severe Chronic Plaque Psoriasis
• A Study to Evaluate Efalizumab in Adults With Plaque Psoriasis, Including Those Who Are Receiving Concomitant Antipsoriatic Therapies
• A Study to Evaluate Raptiva in Subjects With Chronic Moderate or Worse Plaque Psoriasis Who Have Had an Inadequate Response to an Anti-TNF Agent
• Double-blind, Randomised, Placebo-controlled Trial Investigating BIRT 2584 XX in Patients With Moderate/Severe Psoriasis
• Study Evaluating the Safety and Efficacy of Etanercept 50 mg Once Weekly in Subjects With Psoriasis
• Efficacy of Re-treatment With Cimzia® in Subject With Chronic Plaque Psoriasis
• Observational Safety Study of Etanercept (Enbrel) for Treatment of Psoriasis
• A Safety and Effectiveness Study of CNTO 1275 in Patients With Moderate to Severe Plaque-type Psoriasis
• Double-blind, Randomized, Placebo-controlled Phase 3 Study of Etanercept in the Treatment of Psoriatic Arthritis and Psoriasis
• A Study to Evaluate the Safety and Efficacy of Efalizumab in Adult Patients With Plaque Psoriasis Involving the Hands and/or Feet
• A Study of the Safety and Efficacy of Ustekinumab (CNTO 1275) in Patients With Moderate to Severe Psoriasis
• Phase I Study of BMS-188667 (CTLA4Ig) in Patients With Psoriasis Vulgaris
• A Safety and Efficacy Study to Evaluate Efalizumab in Combination With UVB for Moderate to Severe Psoriasis
• Study to Evaluate the Efficacy of Alefacept to Treat Palmar Plantar Pustulosis
• CYA Versus MMF for Treatment of Moderate-Severe Psoriasis.
• A Study to Assess the Safety and Effectiveness of Tacrolimus Cream in the Treatment of Psoriasis
• A Study to Assess the Long-Term Safety of Tacrolimus Cream in the Treatment of Psoriasis
• A Study to Assess the Safety and Effectiveness of Tacrolimus Cream in the Treatment of Psoriasis
• Study Evaluating the Safety and Efficacy of Etanercept in Patients With Psoriatic Arthritis Treated by Rheumatologists
• Study Evaluating the Safety and Efficacy of Etanercept in Patients With Psoriatic Arthritis Treated by Dermatologists
• Efficacy and Safety of ABT-874 in Subjects With Moderate to Severe Chronic Plaque Psoriasis
• Phase II Randomized, Double-Blind, Placebo-Controlled Study of BMS-188667 (CTLA4Ig) in Patients With Psoriasis Vulgaris
• A Multicentre, Open Label Phase IIIb/IV Study of Subcutaneously Administered Raptiva in the Treatment of Adult Subjects With Moderate to Severe Plaque Psoriasis
• Efficacy and Safety of Calcipotriene/Betamethasone Gel/Ointment in Psoriasis
• A Study to Assess the Pharmacokinetics, Immunogenicity and Safety of Escalating Doses of BMS-188667 Given as a Single Intravenous Infusion to Patients With Psoriasis Vulgaris
• A Study of Safety and Effectiveness of Ustekinumab (CNTO 1275) in Patients With Moderate to Severe Plaque-type Psoriasis
• Efficacy and Safety of Calcipotriol Plus Betamethasone Dipropionate Gel in Psoriasis Vulgaris
• A Long-term Safety Study of Infliximab (Remicade)
• A 36-Week Extension to Protocol ISA04-03
• CLEAR Study: Clinical Experience Acquired With Raptiva Study
• The Effects of Infliximab Versus Methotrexate in the Treatment of Moderate to Severe Psoriasis (Study P04271AM2)(COMPLETED)
• A Study of Efalizumab in Participants With Moderate to Severe Chronic Psoriasis Who Have Failed, Have a Contraindication to, or Are Intolerant of Other Systemic Therapies
• Efficacy and Safety of Calcipotriol Plus Betamethasone Dipropionate Ointment in Patients With Psoriasis Vulgaris
• Efficacy Study of CDP870 in Subjects With Chronic Plaque Psoriasis Who Are Candidate for Systemic Therapy and/or Phototherapy/Photochemotherapy
• Randomized Placebo-Controlled Study of ISA247 in Plaque Psoriasis
• Efficacy of Calcipotriol Plus Betamethasone Gel Versus Calcipotriol Scalp Solution in Scalp Psoriasis
• Efficacy and Safety of Adalimumab in Subjects With Moderate to Severe Chronic Plaque Psoriasis
• Evaluation of Topical Antipsoriatics in the Psoriasis Plaque Test
• Study of the Efficacy, Safety and Tolerability of Oral CEP-701 in Patients With Severe Psoriasis
• Safety and Efficacy of Adalimumab to Methotrexate and Placebo in Subjects With Moderate to Severe Chronic Plaque Psoriasis
• Curcuminoids for the Treatment of Chronic Psoriasis Vulgaris
• Safety and Tolerability of Repeat Courses of IM Alefacept
• A Safety and Efficacy Study of Infliximab (Remicade) in Patients With Plaque Type Psoriasis
• The RATIO: Registry of Infections and Lymphoma in Patients Treated With TNF-a Antagonists
• Efficacy and Safety of Calcipotriol Cream and (Calcipotriol + Betamethasone Dipropionate) Ointment in Psoriasis Vulgaris
• Efficacy and Safety of Calcipotriol Plus Betamethasone Dipropionate Gel for up to a Year in Scalp Psoriasis
• Efficacy and Safety of Calcipotriol Plus Betamethasone Dipropionate Gel in Scalp Psoriasis
• Efficacy and Safety of Calcipotriol Plus Betamethasone Gel in the Treatment of Scalp Psoriasis
• Phase 2 Clinical Study in Psoriasis With Oral Investigational Drug VX-765
• Efficacy and Safety of Adalimumab in Subjects With Moderate to Severe Chronic Plaque Psoriasis
• Study Evaluating Etanercept in the Treatment of Subjects With Psoriasis
• Study of MEDI-522 Administered by Subcutaneous Injection to Adults With Plaque Psoriasis
• Study of MEDI-507 Administered by Intravenous Infusion to Adults With Plaque Psoriasis
• Classification and Characterization of Patients Treated With Efalizumab for Plaque Psoriasis
• Community Based Trial for AMEVIVE®
• Study of BMS-587101 in Patients With Moderate to Severe Psoriasis
• Study Evaluating Etanercept and Methotrexate in Plaque Psoriasis
• Acitretin and Etanercept in Psoriasis
• Bexarotene With Narrow-Band UVB for Psoriasis
• Alefacept Mechanism of Action in Psoriasis
• Safety and Efficacy Study of MM-093 in Patients With Chronic Plaque Psoriasis
• Neuroskin Forte for Dry Skin Relief in Eczema and Psoriasis
• Transitioning From Cyclosporine to Alefacept in Psoriasis
• Pediatric Open-Label Extension Study of Etanercept in Patients With Plaque Psoriasis
• Etanercept With Tacrolimus for Psoriasis
• Study of Etanercept in the Treatment of Psoriasis in Adult Subjects
• Study to Help Understand the Action of the Drug Etanercept for the Adult Patient With Psoriasis
• Study of the Drug Efalizumab (Raptiva), for Adult Patients With Moderate to Severe Plaque Psoriasis
• A Study of Tetrathiomolybdate in the Treatment of Psoriasis Vulgaris
• Evaluating the Safety of Etanercept 50 mg Twice Weekly in Subjects With Psoriasis
• Evaluating the Safety of Etanercept in the Treatment of Psoriasis in Adult Subjects
• Enbrel® in Psoriatic Arthritis
• An Evaluation of Etanercept in the Treatment of Subjects With Psoriasis
• Utilization of Narrow Band Ultraviolet B (UVB) Light Therapy and Etanercept for the Treatment of Psoriasis
• A Study to Evaluate Raptiva in Adults With Moderate to Severe Plaque Psoriasis Who Are Candidates for Systemic Therapy
• A Study to Evaluate Raptiva in Adults With Plaque Psoriasis Previously Enrolled in Study ACD2390g
• A Study of the Safety and Effectiveness of Infliximab in Patients With Plaque-type Psoriasis
• A Study of the Safety and Efficacy of Infliximab in Patients With Psoriasis
• A Study to Evaluate Raptiva in Combination With Topical Psoriasis Therapies
• A Study to Evaluate the Safety of Raptiva in Adults With Plaque Psoriasis Previously Enrolled in Study ACD2600g
• Onercept in the Treatment and Re-Treatment of Subjects With Moderate to Severe Plaque Psoriasis
• Etanercept (Enbrel®) in Psoriasis - Pediatrics
• To Study the Use of Humanized CD25 in Preventing the Relapse of Psoriasis Vulgaris
• To Study the Effects of CD25 and Low Dose Cyclosporin in the Treatment of Active Psoriasis Vulgaris
• Treatment of Psoriasis With Parathyroid Hormone
• Micellar Paclitaxel to Treat Severe Psoriasis
• Study of Topical Calcitriol in Children With Psoriasis
• Conditioning, the Placebo Effect, and Psoriasis
• Study of Topical Calcitriol or Oral Calcitriol in Patients With Psoriasis
• A Study of Retrovir in the Treatment of Psoriasis in HIV-Positive Patients
• Treatment of Psoriasis Using Acitretin in HIV-Positive Patients
• Randomized Double-Blind Placebo-Controlled Trial Using Recombinant Human Interleukin-10 for Moderate-to-Severe Psoriasis
• A Controlled Trial of Intermittent Fludarabine for Psoriatic Arthritis